PresentationsMichael Laposata, MD, PhD

Michael Laposata - Invited Lectures & Conferences

• Invited Lectures at Symposia and Conferences

  Academy of Clinical Laboratory Physicians and Scientists National Meeting, Philadelphia, PA. June 1987. "Control of Prostaglandin Production by Fatty Acid Supply."

  Academy of Clinical Laboratory Physicians and Scientists National Meeting, Philadelphia, PA. June 1987. "Monitoring Anticoagulant Therapy."

  Blood Bank Association of New York State Annual Meeting, Syracuse, NY. June 1988. "Secondary Hemostasis."

  Association of Pathology Chairperson's Annual Meeting, Aspen, CO. July 1990. "Why Medical Students Choose Careers in Pathology."

  American Society of Hematology/International Society of Hematology, Boston, MA. December 1990. "Clinical Utility of Platelet Aggregometry."

  General Surgery Continuing Education Course, Harvard Medical School, Boston, MA. September/October 1990-1995 (annually). "Preoperative and Postoperative Evaluation of Hemostasis."

  American Society of Clinical Pathologists National Meeting, Nashville, TN. March 1991. "Development of a Residency Training Program in Laboratory Medicine."

  Hungarian National Academy of Sciences, Budapest, Hungary. September 1991. "Laboratory Medicine Training in the United States."

  The Ontario Medical Association Annual Meeting, Toronto, Canada. October 1991. "The Rapidly Evolving Specialty of Laboratory Medicine."

  Academy of Clinical Laboratory Physicians & Scientists National Meeting, San Francisco, CA. June 1992. "Laboratory Medicine Teaching Programs for Medical Students in the Basic Science Curriculum."

  Canadian Association of Pathologists National Meeting, Toronto, ONT. June 1992. "The Role of the Clinical Laboratory in Patient Care".

  42nd Congress of the Hungarian Society of Clinical Pathology, Veszprem, Hungary. September 1992. "The Practice of Clinical Pathology in the U.S."

  ASCP/CAP National Meeting, Las Vegas, NV. October 1992. "Graduated Responsibility for Residents in Clinical Pathology."

  Coagulation Resource Committee of the College of American Pathologists, Lake Buena Vista, FL. January 1993. "Bedside Testing in Coagulation."

  ASCP/CAP National Meeting, Multiple Sites. 1992-1995 (annually). "Lipids: Biochemistry to Clinical Significance." Half-Day Workshop.

  Mid-Atlantic Lipid Research Symposium, Atlantic City, NJ. May 1994. "The Covalent Binding of Fatty Acids to Proteins: A Metabolic Pathway of Increasing Complexity."

  Second International Round Table Conference on Fatty Acids in Cell Signaling (35 scientists by invitation only), Madison, WI. June 1994. "Fatty Acid Ethyl Esters: Toxic Ethanol Metabolites."

  Northeast Chapter of the American Association for Clinical Chemistry, October 1994. "Alternate Site Laboratory Testing."

  ASCP/CAP National Meeting, Washington, D.C. October 1994. "The Introductory Rotation in Clinical Pathology Residency Training."

  ASCP/CAP National Meeting, Washington, D.C. October 1994. "Stump the Stars: Review of Clinical Cases by Expert Panelists."

  ASCP/CAP National Meeting, Washington, D.C. October 1994. "Should This Test Be Done: Lipid Screening Tests."

  Management Decisions for the General Surgeon Continuing Education Course, Harvard Medical School, Boston, MA. October 1994. "Necessity for Blood Transfusion Therapy" and September 1995 "The Diagnosis of Hypercoagulable States."

  Anesthesia Review and Update Continuing Education Course, Harvard Medical School, Boston, MA. 1994-2013 (annually). "Why Doesn’t the Blood Clot?"

  Intensive Care Medicine Continuing Education Course, Harvard Medical School, Boston, MA. 1994-2007 (annually). "Diagnosis and Management of Coagulation Disorders."

  Annual Review for Dental Practitioners - Continuing Education Course, Harvard Medical School, April 1994-1996 (annually). "Coagulopathies."

  College of American Pathologists Symposium on Alternate Site Testing, Washington, DC. January 1995. "A Successful Model of Bedside Glucose Testing."

  Fifth Annual Symposium on Coagulation Testing Sponsored by the Bio-Data Corporation, Philadelphia, PA. March 1995. "Bedside Coagulation Testing."

  Ninth Annual Meeting of Northeast Section of American Association of Clinical Chemistry, Clinical Laboratory Management Association, and Clinical Ligand Society, Danvers, MA. May 1995. "Cost & Quality in Point-of-Care Testing."

  International Society for the Study of Fatty Acids & Lipids (ISSFAL), Bethesda, MD. June 1995. "Thioesterification of Platelet Proteins with Saturated and Polyunsaturated Fatty Acids."

  ASCP/CAP National Meeting, New Orleans, LA. September 1995. "Bedside Glucose Testing: The Facts and Nothing but the Facts."

  Tenth Annual Meeting of the Northeast Section of the Clinical Laboratory Management Association and the Clinical Ligand Assay Society, Boxborough, MA. May 1996. "Point of Care Testing at the Massachusetts General Hospital."

  Scientific Symposium on Anticoagulation Monitoring, Dedham, MA. June 1996. "The Therapeutic Use and Clinical Laboratory Monitoring of Low Molecular Weight Heparin."

  Third International Round Table Conference on Fatty Acids in Cell Signaling (35 scientists by invitation only), Maastricht, The Netherlands. July 1996. Fatty Acids Covalently Bound to Platelet Proteins in the Native State."

  20th Annual Arnold O. Beckman Conference. New Orleans, LA. February 1997. "Alcoholic Liver Disease: Short Term and Long-Term Markers of Ethanol Intake."

  Biomedical Marketing Association, Boston, MA. March 1997. "Maximizing the Output and Diagnostic Testing in the Clinical Laboratory."

  ASCP Advisory Council Meeting. Chicago, IL. April 1997. "Clinical Pathology: Its Evolution into a Laboratory Test Interpretive Service Indispensable to Clinicians."

  American Association for Clinical Chemistry/Clinical Ligand Society, Boston, MA. May 1997. "Cardiology & the Clinical Laboratory: Thrombosis and Hemostasis in Myocardial Infarction.”

  American Association of Clinical Chemistry National Meeting, Atlanta, GA. July 1997. "The Clinical Impact of Point of Care Testing."

  Controversies in Critical Care, Society of Critical Care Medicine Meeting, Boston, MA. September 1997. "Does Point of Care Testing Improve Patient Care and Is It Cost Effective?"

  Integrating Point-of-Care Testing with Continuity of Care: Effects on Outcome, Meeting of the National Academy of Biochemistry. Philadelphia, PA. September 1997. "Case Studies on Point of Care Testing."

  ASCP/CAP National Meeting, Philadelphia, PA. September 1997. "The New Role of the Pathologist as a Direct Medical Consultant."

  Breakthroughs in Pathology, National ASCP/CAP meeting, Philadelphia, PA. September 1997. "New Markers for Monitoring Ethanol Intake."

  College of American Pathologists Consensus Conference on Anticoagulant Monitoring. Atlanta, GA. October 1997. “Leader of Session to Formulate Recommendations for Monitoring Low Molecular Weight Heparin, Danaparoid, Hirudin, and Argatroban.”

  Northeastern Chapter, American Association of Clinical Chemistry meeting, Waltham, MA. November 1997. "Chemical Diagnosis of Alcoholism."

  College of American Pathologists Conference on Automated Information Management in the Clinical Laboratory, Ann Arbor, MI. May 1998. "The Pathologist as a Direct Medical Consultant."

  Academy of Clinical Laboratory Physicians and Scientists National Meeting, Boston, MA. June 1998. "Narrative Interpretations in the Clinical Laboratory: The Basic Concepts."

  International Society for the Study of Fatty Acids and Lipids (ISSFAL). Lyon, France. June 1998. "Covalent Modification of Proteins by Fatty Acids."

  International Society for the Study of Fatty Acids and Lipids (ISSFAL). Lyon, France. June 1998. "Fatty Acid Ethyl Esters: Nonoxidative Metabolites of Ethanol."

  Fourth International Roundtable on Fatty Acids in Cell Signaling, (30 scientists by invitation only) Chatham, MA. June 1998. "Fatty Acid Ethyl Esters: Ethanol Metabolites with a Role in Organ Damage and Ethanol Monitoring."

  Biomedical Marketing Association, Philadelphia, PA. August 1998. "Current Trends in Clinical Laboratories."

  Brazilian Congress of Clinical Pathology, Rio de Janeiro, Brazil. September 1998. "Redefining Expectations of Clinical Laboratory Services."

  Association of Pathology Chairpersons - Northeast Section, Bermuda. October 1998. "The Added Value of the Clinical Pathologist in the Practice of Laboratory Medicine."

  College of American Pathologists Conference on Automated Information in the Clinical Laboratory, Executive Briefing, Ann Arbor, MI. May 1999. “Enhanced Clinical Consulting: Getting Closer to the Sweet Spot.”

  Fourth International Bayer Diagnostics Laboratory Testing Symposium, Tucson, AZ. June 1999. “A Clinician’s View of the Future.”

  Associations of Pathology Chairs/Pathology Residency Program Directors Meeting, Boulder, CO. July 1999. Workshop entitled, “Training Pathologists to be Clinical Consultants: Providing Added Value-Let’s Get Real!”

  ASCP/CAP National Meeting, New Orleans, LA. September 1999. “Clinical Pathology Narrative Interpretations - How to do Them and How to Get Paid for Them.”

  Conference of Maine Physicians, Scarborough, ME. October 1999. “Low Molecular Weight Heparin: When and How to Use it and Monitor its Effect.”

  Advancing Pathology Informatics, Imaging and the Internet, Pittsburgh, PA. October 1999. “The Pathologist as Digital Consultant: The Enhanced Clinical Consultation.”

  American Society for Clinical Laboratory Scientists 1999 National Meeting for Advanced Hematology and Hemostasis, Providence, RI. October 1999. “Providing More than Just a Coagulation Test Result: The Value-Added Clinical Laboratory Services at the Massachusetts General Hospital.”

  7th Annual Progress in Clinical Pathology, Dallas, TX. March 2000. “Diagnosis and Treatment of Hypercoagulability.”

  American Association for Clinical Chemistry, Connecticut Valley Section, Hartford, CT. March 2000. “One of Five is Predisposed to Thrombosis - Are You One and Do You Want to Find Out?”

  Twelfth Annual Lectures in Contemporary Hemostasis and Thrombosis, Miami, FL. March 2000. “Diagnostic Mistakes in Coagulation with Catastrophic Outcomes.”

  7th Annual Progress in Clinical Pathology, Dallas, TX. March 2000. “Redefining the Role of the Clinical Laboratory: Clinical Pathology for the New Millennium.”

  Resident Physician Forum, American Society of Clinical Pathologists National Meeting, Boston, MA. April 2000. “Emerging Changes in the Field of Laboratory Medicine.”

  New England Sunquest Users Group, Sturbridge, MA. April 2000. “The Value-Added Clinical Laboratory Services at the Massachusetts General Hospital.”

  2000 Executive War College on Lab and Pathology Management, New Orleans, LA. May 2000. “Clinical Pathology Professional Services for Which Managed Care Companies Will Reimburse.”

  Evidence-Based Medicine: Optimizing Decision-Making to Improve Patient Care, Arlington, VA. May 2000. “The Role of Evidence-Based Medicine in Medical Decision Making-Case Studies in Hemostasis” and “Techniques to Improve Physicians’ Use of Diagnostic Tests.”

  The 5th International Bayer Diagnostics Laboratory Symposium, Seville, Spain. June 2000. “The Future and Ethics of Screening and Preventive Medicine.”

  Symposium on Anticoagulation Management in the 21st Century, Brooklyn, NY. June 2000. “Outpatient Management of Deep Vein Thrombosis Using Low Molecular Weight Heparin.”

  Role of the Laboratory in the Treatment of Patients, Mayo Symposium, Prouts Neck, ME. June 2000. “The Diagnosis and Treatment of Hypercoagulable States.”

  Sharp Health Care, Educational Symposium for the Physicians in the Sharp Health Care System, San Diego, CA. October 2000. “Reducing Error through Appropriate Test Ordering.”

  ASCP/CAP National Meeting, San Diego, CA. October 2000. “Clinical Pathology Narrative Interpretations: How to Do Them and How to Get Paid.”

  Illinois Society of Pathologists 2000 Fall Meeting, Rosemont, IL. November 2000. “A Complete Re-Definition of the Services Provided by the Clinical Laboratory.”

  American Association of Clinical Chemistry and the College of American Pathologists Symposium on the Clinical Laboratory Meets the Internet, Miami, FL. February 2001. “Enhanced Clinical Consulting Meets the Web.”

  2001 Executive War College on Lab and Pathology Management, Cincinnati, OH. May 2001. “Converting Lab Test Results into the Value-Added Services Wanted by Physicians and HMOs” and “Doing It Right: How Clinical Pathologists Can Build Value-Added Professional Opinions into Lab Test Reports.”

  Automated Information Management in the Clinical Laboratory Symposium, Ann Arbor, Michigan. May 2001. “Enhanced Clinical Consulting: Moving Toward the Core Competencies of Lab Professionals.”

  Symposium on Expanding the Horizons of Antithrombotic Therapy, Staten Island, NY. May 2001. “Diagnosis and Treatment of Hypercoagulable States”.

  24th Annual Meeting of the Research Society on Alcoholism, Montreal, Canada. June 2001. “Role of Fatty Acid Ethyl Esters in Alcohol Induced Organ Damage.”

  Cellular & Molecular Aspects of Omega-3 Fatty Acids and Cancer Symposium, Breckenridge, CO. June 2001. “Fatty Acid Metabolism in Chronic Alcoholism, an Induction State for Hepatocellular Carcinoma.”

  The Fifth International Conference on Fatty Acids and Cell Signaling, Gargano, Italy. September 2001. “Fatty Acid Ethyl Esters: Their Role in Ethanol – Induced Cell Injury and Monitoring Ethanol Intake.”

  ASCP/CAP National Meetings, Philadelphia, PA. October 2001. “The Clinical Laboratory Meets the Internet: Strategies and Solutions.”

  International Conference on Laboratory Medicine – Continuous Education, Duties, and Responsibilities of Professionals in Medical Laboratories, Padua, Italy. October 2001. “Enhanced Clinical Consulting: Moving Toward the Core Competencies of Laboratory Professionals.”

  Lab Med 2001 Symposium, New York City, NY. October 2001. “Genetic Markers of Hemostasis.”

  Audioconference for American Association for Clinical Chemistry. February 2002. “Point of Care Testing for Coagulation.”

  18th Annual Regional Meeting of the Clinical Laboratory Managers Association, Pittsburgh, PA. March 2002. “Redefining Expectations from the Clinical Laboratory.”

  9th Annual Progress in Clinical Pathology Symposium, Dallas, TX. April 2002. “Medical Errors in Reality” & “Evidenced-Based Medicine-Identifying Appropriate Tests for the Evaluation of Thrombophilia.”

  The Massachusetts Society of Pathologists Spring CME Program. Newton, MA. April 2002. “The Diagnosis and Treatment of Hypercoagulable States.”

  19th Annual Hemostasis & Thrombosis Update, Philadelphia, PA. April 2002. “The Diagnosis & Treatment of Hypercoagulable States.”

  The 16th Annual Northeast Region Meeting of the Clinical Laboratory Management Association, Clinical Ligand Society and American Association of Clinical Chemistry. Boxborough, MA. April 2002. “The Diagnosis & Treatment of Hypercoagulable States.”

  “Issues in the Treatment of Women” symposium of the American College of Obstetricians and Gynecologists, Burlington, MA, July 2002. The Johns Figgs Jewet Memorial Lectureship “Thrombophilia in Pregnancy.”

  Greater New York Clinical Laboratory Management Association Program on the Early Diagnosis of Life Threatening Sepsis and DIC, New York City, NY, July 2002. “Sepsis, Coagulation, and a Drug That Connects Them.”

  54th National Meeting of the American Association of Clinical Chemistry, Orlando, FL, July 2002. “Point of Care Coagulation Testing,” “The Diagnosis of Bleeding Disorders,” and “The Diagnosis of Thrombotic Disorders” (3 invited talks).

  Dade Fall Conference 2002, Waltham, MA. September 2002. “The Diagnosis & Treatment of Hypercoagulable States.”

  Hawaii Society of Pathologists, Honolulu, HI. October 2002. “Redefining Expectations from the Clinical Laboratory.”

  Birmingham Fall Hemostasis Symposium, Birmingham, AL. October 2002. “Hypercoagulable States.”

  American Thrombosis Institute, Public Educational Symposium on Thrombosis, Mountain Brook, AL. October 2002. “Blood Clots – Am I at Risk?”

  XVI Congress Latinoamericano de Patologia Clinica VI and Congreso Iberoamericano de Medicina Tansfusion, Acapulco, MX. November 2002. “Redefinition of Clinical Laboratory Services.”

  Safe Transitions in Anticoagulation Therapy Symposium, Boston, MA. February 2003. “Overview of Normal Hemostasis and Thrombosis.

  Houston City Wide Hematology Conference, Houston, TX. March 2003. “Hypercoagulable States and the 2001 Consensus Conference Recommendations for Thrombophilia Testing.”

  New York State Society of Pathologists, 34th Annual Continuing Education Meeting, Binghamton, NY. May 2003. “Hypercoagulability.”

  Dade Behring Hemostasis Symposium, Raleigh-Durham, NC. May 2003. “A Complete Redefinition of the Services Provided by the Clinical Laboratory.”

  Automated Information Management in the Clinical Laboratory, 21st annual symposium, Ann Arbor, MI. May 2003. “How to Turn Laboratory Consulting into a Revenue-generating Operation.”

  Dade Behring Hemostasis Symposium, Raleigh-Durham, NC. May 2003. “A Complete Redefinition of the Services Provided by the Clinical Laboratory.”

  Automated Information Management in the Clinical Laboratory, 21st annual symposium, Ann Arbor, MI. May 2003. “How to Turn Laboratory Consulting into a Revenue-generating Operation.”

  The 6th International Conference on Fatty Acids and Cell Signaling. Bethesda, MD. July 2003. “Fatty Acid Ethyl Esters in Red Blood Cells and Platelets.”

  Alcohol Birth through Death Conference sponsored by the California Association of Toxicologists. Santa Rosa, Ca. August 2003. “Fatty Acid Ethyl Esters as Postmortem Markers of Premortem Ethanol Intake.”

  30th Meeting of the New England Society for Vascular Surgery, Newport, RI. September 2003. “Diagnosis of Hypercoagulable States.”

  Advances in Rheumatology, Continuing Education Course, Harvard Medical School, Boston, MA. September 2003. “Hypercoagulability Testing: Current Practice to Assess Thrombotic Risk.”

  Cancer Medicine and Hematology, Harvard Medical School Continuing Education Course, September 2003. “Case Management Problems in Coagulation

  Washington G-2 reports, 21st Annual Lab Institute. Arlington, VA. October 2003. “Lab & Pathology Trailblazers: Early Adapter Solutions and Strategies.”

  Washington G-2 reports, Achieving Outreach Leadership for Lab & Pathology Services: Positioning your Program for Success, Atlanta, GA. February 2004. “Succeeding in the Outreach Market: Applying Critical IT Solutions.”

  Frontiers in Laboratory Medicine 2004: Changing Process, Improving Outcomes, Manchester, England. February 2004. “Making Laboratory Medicine More Valuable to Physicians and Patients.”

  Cardiology and Cardiac Surgery Practice Management Rounds, Massachusetts General Hospital, Boston, MA. February 2004. “The Pathogenesis, Diagnosis, and Treatment of Heparin-Inducted Thrombocytopenia.”

  Lab Infotech Summit, Las Vegas, NV. March 2004. “Clinical Laboratory Consulting: Quality and Financial Implications.”

  5th Annual Louisiana Coagulation Conference, Metairie, LA. March 2004. “Diagnosis and Treatment of Thrombophilic States.”

  Centers for Disease Control and Prevention, Quality Institute Conference on “Making the Laboratory a Key Partner in Patient Safety,” Atlanta, GA. April 2004. “Reducing Medical Errors by Providing Expert Advice in the Selection and Interpretation of Laboratory Tests.”

  Association of Clinical Scientists, Abraham J. Gitlitz Memorial Lecture as Keynote address at 124th Annual Meeting, Houston, TX. May 2004. “The Future of Physicians in Laboratory Medicine.”

  Harvard Medical School Anesthesia Review and Update 2004, Boston, MA. May 2004. “Why Doesn’t the Blood Clot and Why Does the Blood Keep Clotting?”

  17th Annual Research Conference of the Cystic Fibrosis Foundation, Williamsburg, VA. June 2004. “Fatty Acid Metabolism in Cystic Fibrosis: What Have We Learned in 20 Years and Where Do We Go From Here?”

  University of Rome, Study Group on Liver Disease and Alcoholism, Rome, Italy. June 2004. “Fatty Acid Ethyl Esters: Toxic Nonoxidative Metabolites of Ethanol.”

  Society of Hospital Medicine, 2004 Northeast Regional Meeting, Boston, MA. June 2004. “Anticoagulants for the Practicing Hospitalist: Monitoring of New Agents, Pitfalls in the Use of Older Agents.”

  Current Concepts in Hemostasis Symposium, John F. Kennedy Library and Museum, Boston, MA. June 2004. “Hypercoagulable States: Their Role in Thrombosis with Air Travel, Pregnancy, and Estrogen Supplementation.”

  Clinical Laboratory Management Association (CLMA), Bay State Chapter, Boston, MA. September 2004. “Laboratory Practices to Increase Patient Safety and Decrease Errors.”

  Advances in Anticoagulation Symposium, Massachusetts General Hospital, Boston, MA. October 2004. “The Coagulation Cascade and Patients at Risk” and “Heparin-Inducted Thrombocytopenia.”

  Top Challenges in Laboratory Medicine Management, American Association of Clinical Chemistry, Dallas, TX. December 2004. “Clinical Utility: Making the Most of your Results.”

  Diagostica Stago National Sales Meeting, Palm Springs, CA. February 2005. “Characteristics of the Ideal Coagulation Laboratory Service Representative.

  College of American Pathologists, National House of Delegates Meeting, San Antonio, TX. February 2005. “The Role of the Laboratory Medical Director.”

  2005 Institute for Quality in Laboratory Medicine Conference. Atlanta, GA. April 2005. “Ask the Experts Session.”

  Coagulation Symposium sponsored by Diagnostica Stago, New York City, NY. May 2005. “Thrombophilia.”

  Current Concepts and Controversies in Vascular and Endovascular Surgery Symposium, Boston, MA. May 2005. “What Surgeons Need to Know about Hypercoagulable States” and “HIT Syndrome: A Major Concern.”

  Anesthesia Review and Update 2005, Boston, MA. May 2005. “Why doesn’t the blood clot and why does it clot too much?”

  Scientific Symposiums, Hilton Head, SC. June 2005. “Bleeding Disorders.”

  Scientific Symposiums, Hilton Head, SC. June 2005. “Hypercoagulable States.”

  Scientific Symposium, Hilton Head, SC. June 2005. “Alcohol: The Good and the Bad.”

  Scientific Symposium, Hilton Head, SC. June 2005. “Evaluation of Cardiovascular Risk.”

  Harvard Medical School Continuing Education Course, Updates in Laboratory Medicine, Boston, MA. June 2005. “Anticoagulants.”

  2005 Annual Meeting of the American Association for Clinical Chemistry, Orlando, FL. July 2005. “Value-Added Test Ordering and Interpreting Services Improve Safety and Effectiveness in Healthcare.”

  2005 Annual Meeting of the College of American Pathologists, Chicago, IL. September 2005. “Pathologist-Physician Communication,” a presentation as part of the Practice Management Institute: Service and Quality.

  Harvard Medical School Continuing Education Course, Advances in Rheumatology, Boston, MA. September 2005. “Coagulopathies.”

  Harvard Medical School Continuing Education Course, Cancer Medicine and Hematology, Boston, MA. September 2005. “Errors in Diagnosis: Thrombosis and Hemostasis Core Studies.”

  Clinical Diagnostics: Creating Greater Value, Industry Sponsored Symposium, Boston, MA. October 2005. “The Health Economics of Biomarkers in Cardiopulmonary Disease” (one of 7 plenary session talks following keynote address by Novelist, Dr. James Watson).

  Current Concepts in Hemostasis, Industry Sponsored Symposium, National Constitution Center Museum, Philadelphia, PA. October 2005. “The Diagnosis and Treatment of Hypercoagulable States.”

  Florida Society of Pathologists National Meeting. Orlando, FL. January 2006. “What the Busy Pathologist Needs to Know about Running a Clinical Laboratory.”

  12th Annual Massachusetts Prosecutors Conference, Boston, MA. March 2006. “Operating Under the Influence”

  Molecular Pathology Meets the Business of Pathology, Spring Conference of the Illinois Society of Pathologists, Oak Brook, IL. April 2006. “Value Added Clinical Pathology Services: What they are and Barriers to their Implementation.”

  Current Concepts and Controversies in Vascular and Endovascular Surgery Symposium, Boston, MA. May 2006. “New Age Anticoagulants” and “HIT: A New Major Problem.”

  Current Concepts and Controversies in Vascular and Endovascular Surgery Symposium, Boston, MA. May 2006. “New Age Anticoagulants” and “HIT: A New Major Problem.”

  Harvard Medical School Anesthesia Review and Update 2006, Boston, MA. May 2006. “Why Doesn’t the Blood Clot and Why Does the Blood Keep Clotting?”

  In Vein: Treatment and Techniques Symposium, Uncasville, CT, June 2006. “Hypercoagulable States: A Primer for the Office Based Physician.”

  American Association of Clinical Chemistry Annual Meeting, Chicago, IL. July 2006. “Coagulation Testing: The Role of the Laboratory Director in Optimizing Patient Outcome.”

  In Vein: Treatment and Techniques Symposium, Uncasville, CT, June 2006. “Hypercoagulable States: A Primer for the Office Based Physician.”

  American Association of Clinical Chemistry Critical & Point-of-Care Testing Division, 4th Annual POC Coordinators Forum, Chicago, IL. July 2006. “Anticoagulation with Warfarin and Heparin: How the Drugs Work, How They are Monitored, and What the Results Mean” and “Point of Care Testing in Coagulation: Barriers to Effective Implementation.”

  College of American Pathologists Annual Meeting, San Diego, CA, September 2006. “Practice Management Institute, Service and Quality.”

  College of American Pathologists Annual Meeting, San Diego, CA. September 2006. “What the Pathologist Director Should Be Doing.”

  College of American Pathologists Annual Meeting, San Diego, CA. September 2006. “Pitfalls in Diagnosis.”

  Cancer Medicine and Hematology, Harvard Medical School Continuing Education Course. September 2006. “Case Studies in Hemostasis”.

  Research Conference on Autism, Boston, MA. October 2006. “Fatty Acid Metabolism – Is It Relevant to Autism?”

  The Ohio Society of Pathologists, Fall Meeting, Columbus, OH. October 2006. “What We Are Doing or Should Be Doing in Clinical Pathology.”

  Critical Care and Trauma Symposium, Boston, MA. November 2006. “Diagnosing a Coagulopathy in the ICU.”

  Sixth Annual Florida East Coast Point of Care Conference, Cocoa Beach, FL. November 2006. “POCT in Coagulation: The INR and Much More”.

  Vascular and Abdominal Interventional Radiology Conference, Massachusetts General Hospital, Boston, MA. February 2007. “Old Age and New Age Anticoagulants: How They Are Used, How They Are Monitored, and How They are Reversed.”

  Massachusetts General Hospital Vascular Summit: A Comprehensive Update for the Primary Care Provider, Boston, MA. March 2007. “Special Course Lecture: Hypercoagulable States: Update on How, Who, and When to Screen.”

  New England Pathology Resident Forum. Boston, MA. April 2007. “Coagulation Disorders.”

  New England Regional Chemistry Exposition (NERCE), Boxborough, MA. April 2007. “The Diagnosis and Treatment of Hypercoagulable States.”

  Anesthesia Review and Update, Harvard Continuing Medical Education Symposium, Boston, MA. May 2007. “Why Doesn’t the Blood Clot?” and “Why Does the Blood Keep Clotting?”

  Pulmonary and Critical Care, Harvard Continuing Medical Education Symposium, Boston, MA. May 2007. “Coagulation.”

  Contemporary Practice of Vascular and Endovascular Surgery: What the Vascular Surgeon Needs to Know, Harvard Continuing Medical Education Symposium, Boston, MA. June 2007. “Hypercoagulable States, Heparin-Induced Thrombocytopenia, and New Age Anticoagulants.”

  Cancer Related Emergencies Symposium, Massachusetts General Hospital, Boston, MA. June 2007. “Coagulopathies and DIC.”

  Fatty Acids in Cell Signaling – 8th Symposium, Quebec City, Canada. June 2007. “Fatty Acid Alterations in Cystic Fibrosis.”

  75th Annual Meeting of the American Society for Clinical Laboratory Sciences, Closing Keynote Address, San Diego, CA. July 2007. “Going Beyond the Performance of the Laboratory Test: What the Patients Need that Only You Can Give Them.”

  College of American Pathologists National Meeting, Chicago, IL. October 2007. Moderator and Speaker at Half-Day Workshop entitled “Practice Management Institute: Adding Value – The Indispensable Pathologist.”

  21st Annual North American Cystic Fibrosis Conference, Anaheim, CA. October 2007. “A Unifying Theory to Explain How CFTR Leads to the Lipid Abnormalities in CF and Altered Inflammatory Signaling” and “Introduction to Fatty Acid Metabolism.”

  Vascular Medicine Continuing Education Symposium Massachusetts General Hospital, Boston, MA. October 2007. “Anticoagulation Pathways.”

  Lab Institute 2007 G2 Reports, 25th Annual Meeting. Growing Your Lab at the New Frontiers. Arlington, VA, October 2007. “Current Critical Issues: Molecular Diagnostics Testing.”

  Gastroenterology Research Conference, Beth Israel Deaconess Medical Center, Boston, MA. November 2007. “Cystic Fibrosis: Fatty Acid Alterations and Fatty Acid Supplementation.”

  Applying Anatomic and Clinical Pathology to Reach a Diagnosis. Harvard Continuing Medical Education Course. “Lymphangitic Spread of Tumor and DIC” and “Patent Foramen Ovale and Hypercoagulable States.”

  Opening Keynote Address, Business & Financial Strategies for Molecular Diagnostics, Sponsored by Washington G-2 Reports, Cambridge, MA. May 2008. “Molecular Diagnostics: Growing at New Frontiers.”

  Vascular Medicine Annual Meeting, San Diego, CA. June 2008. “Hypercoagulability in Vascular Disease: When Should You Consider This, and What Tests Should You Order?”

  American Association of Clinical Chemistry (AACC) National Meeting, Washington, D.C. July 2008 “Over diagnosis of Child Abuse Due to Undiagnosed Underlying Disease.”

  College of American Pathologists National Meeting, San Diego, CA. September 2008. Moderator and Speaker at Half-Day Workshop entitled “Practice Management Institute: Adding Value – The Indispensable Pathologist.”

  Tennessee Chapter, American Society of Clinical Laboratory Scientists, Nashville, TN. September 2008. “Advising Clinicians on Test Selection and Result Interpretation.”

  13th Annual Anatomic Pathology Informatics (APIII), Pittsburgh, PA. October 2008. “Why Not New Delhi? Is the Local Pathologist Dispensable?”

  Keynote Address for the XXXVIII Mexico Congress on Clinical Pathology, Acapulco, Mexico. October 2008. “The Indispensable Role of the Clinical Pathologist.”

  22nd Annual North American Cystic Fibrosis Conference, Orlando, FL. October 2008. In the session on Fatty Acids: Crossroads of Nutrition and Science, “Monitoring Adequacy of Omega-3 Fatty Acid Intake.”

  American Academy of Pediatrics Premeeting Satellite Session on Diagnosis and Management of Coagulation Disorders, Boston, MA. October 2008. “Diagnosis and Treatment of Common Bleeding Disorders.”

  XXXVIII Mexican Congress on Clinical Pathology, Acapulco, Mexico. October 2008. Half-day symposium on “The Diagnosis and Treatment of Coagulation Disorders.”

  Keynote Address for American Society for Clinical Pathology Leadership Exchange, Philadelphia, PA. March 2009. “Expanding Your Role in Patient Care.”

  American Association of Clinical Chemistry, Professional Practice Course, Alexandria, VA. April 2009. “Diagnosis of Coagulation Disorders.”

  Keynote Address for Clinical Laboratory Scientists of Alaska, Anchorage, AK. May 2009. “Going Beyond the Laboratory Test: What Patients Need that Only You Can Provide.”

  American Association of Clinical Chemistry National meeting, Chicago, IL. July 2009. “The Indispensable Laboratory Director.”

  American Association of Clinical Chemistry Awards Banquet Speaker, Upstate New York section, Verona, NY. October 2009. “The Role of the Laboratorian in Assisting Physicians in Test Selection and Result Interpretation.”

  The Clinical Laboratory Management Association of Central New York and the American Association of Clinical Chemistry Upstate New York sections, Verona, NY. October 2009. “Laboratory Tests in the Diagnosis of Bleeding and Thrombotic Disorders.”

  Harold Bernard Stroke and Neurosciences Symposium, Nashville, TN. November 2009. “Clotting Factors as a Risk for Stroke.”

  American Pathology Foundation Spring Conference, Las Vegas, NV. March 2010. “Clinical Pathology: Overcoming Barriers to Mainstream Implementation.”

  Keynote Address for American Society for Clinical Laboratory Scientists – Tennessee Annual Conference, Nashville, TN. April 2010. “Why Doctors Find It Difficult to Use the Clinical Laboratory Effectively.”

  FDA Symposium, Silver Spring, MD. May 2010. “Cost Effective Laboratory Testing: New Programs to Help the Physician Choose the Right Tests and Correctly Interpret the Test Results.”

  American Association for Clinical Chemistry 2010 Annual Meeting, Anaheim, CA. July 2010. “Interpretive Comments from the Clinical Laboratory: Essential for Patient Safety. Clinical Consultation by Laboratory Directors: Impact on Patient Safety and Outcome.”

  APIII and Lab Info Tech Summit 2010, Boston, MA. September 2010. “Barriers to Clinical Lab Interpretive Reporting.”

  College of American Pathologists Annual Meeting, Chicago, IL. September 2010. “Practice Management College: Adding Value – the Indispensable Pathologist.”

  Washington G-2 Reports, 28th Annual Lab Institute, Arlington, VA. October 2010. “Getting the Best Results: An Evolving Role for Pathologists and Lab Directors.”

  AACC New York Metro Section, New York, NY. May 2011. “Mistakes in Diagnostic Coagulation Made by Others – So You Will Not Make Them Yourself.”

  46th Academy of Clinical Laboratory Physicians and Scientists National Meeting, St. Louis, MO. June 2011. "Managing Send-out Costs – What Have You Tried, What Works and What Doesn’t”

  Keynote Address for Annual Meeting of the American Society for Clinical Laboratory Scientists (with Dr. James Meisel), Atlanta, GA. July 2011. “Getting to the Right Diagnosis with Laboratory Tests as Fast as Possible – The Challenges and Essential Role of the Medical Technologist in the New Healthcare Environment.”

  American Association of Clinical Chemistry National Meeting (with Drs. Julie Taylor, James Meisel, and Paul Epner), Atlanta, GA. July 2011. “Opportunities for Improvement in Physician's Utilization of Laboratory Testing for Better Patient Outcomes.”

  College of American Pathologists National Meeting. Dallas, TX. September. 2011. “The Best of Future scape” and “Antiplatelet Agents and Anticoagulants.”

  APIII and Lab Info Tech Summit 2011, Pittsburgh, PA. October 2011. “Improving Laboratory Test Selection and Results Interpretation.”

  Diagnostic Error in Medicine 2011, 4th International Conference, Chicago, IL, October 2011. “Error in Test Selection and Result Interpretation: A Major Source of Poor Patient Outcome.”

  Academy of Pathology and Laboratory Medicine of Puerto Rico Fall Meeting, Caguas, Puerto Rico. October 2011. “Coagulation Disorders: Thrombosis”, “Coagulation Disorders: Bleeding”, “Consultation by Clinical Pathologists on Laboratory Test Selection and Results Interpretation.”

  2011 American College of Veterinary Pathologists/American Society for Veterinary Clinical Pathology Concurrent Annual Meetings. Nashville, TN. December 2011. “Diagnostic Management Team for Coagulation Disorders: The Expert is Always Available.”

  7th New Orleans Coagulation Conference, Keynote Address. New Orleans, LA. February 2012. “The Diagnostic Management Team in Coagulation at Vanderbilt: How It Works and Its Clinical and Financial Impact.”

  G2 Intelligence, Pathology Institute, 2012. Fort Lauderdale, FL. February 2012. “It Is a New World for Pathology Organizations: Is Your Practice Advising Treating Physicians on Laboratory Tests Selection and Results Interpretation?”

  The American Association for Clinical Chemistry Molecular Pathology Course, Chicago, IL. May 2012. “The PREDICT Program at Vanderbilt: Acceptance by Practicing Physicians of Pharmacogenomic Testing.”

  Association of Pathology Chairs 2012 Meeting. Monterey, CA. July 2012. “Addressing the Challenges of Laboratory Medicine Training in 3-4 Years,” within the Laboratory Medicine and Management Training Forum.

  Blood Bank Association of New York State, New York, NY. June 2012. “New Anticoagulants and Antiplatelet Agents.”

  National Meeting of the American Association for Clinical Chemistry. Los Angeles, CA. July 2012. “Improving Physicians’ Utilization of Laboratory Testing for Better Patient Outcomes.”

  National Meeting of the American Association for Clinical Chemistry. Los Angeles, CA. July 2012. “The Essential Role of Interpretation in the Provision of Laboratory Services,” within the workshop entitled “Enhancing Patient Safety and Patient Care by Effective Utilization of Laboratory Services.”

  American Society for Clinical Laboratory Sciences National Meeting, Keynote Address. Los Angeles, CA. July 2012. “The Technologists Contribution after the Generation of the Test Result: A New Role for the Clinical Laboratory Scientist in the Diagnostic Management Team.”

  College of American Pathologists National Meeting. San Diego, CA. September 2012. Dueling Doctors: A Discussion between Clinician and the Laboratory Director.”

  College of American Pathologists House of Delegates National Meeting. San Diego, CA. September 2012. “How the CAP is Helping You Make It Work in Your Practice: The Diagnostic Management Team.”

  College of American Pathologists National Member Conversation. San Diego, CA. September 2012. One of two panelist pathologists with a moderator discussing the transformation of pathology to a large group of pathologists.

  Pacific Rim Pathology Group, Educational Seminar. San Diego, CA. September 2012. “The Diagnostic Management Team and Vanderbilt.”

  49th Annual Intermountain States Seminar, Keynote Address. Jackson Hole, WY. September 2012. “The Technologists’ Contribution after the Generation of the Test Result: A New Role for the Medical Laboratory Scientist on the Diagnostic Management Team.”

  College of American Pathologists National Meeting, San Diego, CA. September 2012. “Antiplatelet Agents and Anticoagulants.”

  APIII and Info Tech Summit, 2012 Pathology Informatics Symposium. Chicago, IL. October 2012. “The Diagnostic Management Team: How it Works and Its Clinical and Financial Implications.”

  COLA’s Symposium for Clinical Laboratories. Baltimore, MD. October 2012. “Right Diagnosis, Right Lab Test, Right on Time – The Dueling Doctors.”

  Association of Molecular Pathology Annual Meeting on Genomic Medicine. Long Beach, CA. October 2012. “The PREDICT Program at Vanderbilt: Four Drug Interactions and Counting.”

  College of American Pathologists Webinar. November 2012. “Diagnostic Management Teams: Advising Clinicians on Coagulation Laboratory Test Selection and Result Interpretation.”

  College of American Pathologists Webinar (audience >500). February 2013. “Making the Case for Pharmacogenomics Testing: Integration into a Healthcare System.”

  Citywide Transfusion Medicine Symposium, Houston, TX. March 2013. “Making the Case for Pharmacogenomics Testing: Integration into a Healthcare System.”

  Clinical Laboratory Management Association national meeting, Orlando, FL. April 2013. “Medical Mistakes with Bad Outcomes: Selecting the Wrong Laboratory Tests and Misinterpreting Test Results -- Who Can Help?”

  American Society for Clinical Laboratory Sciences – North Dakota Annual Meeting. Grand Forks, ND. Keynote Address. April 2013. “The Technologists’ Contribution after the Generation of the Test Result: A New Role for the Clinical Laboratory Scientist on the Diagnostic Management Team.”

  7th New Insights into Coagulation: New Anticoagulants in 2013, Philadelphia, PA. May 2013. “The Coagulation Diagnostic Management Team: How it Works and its Clinical Impact.”

  Symposium on Benign Prostatic Hyperplasia, Nashville, TN. June 2013. “Fatty Acid Changes in Cystic Fibrosis: Are They Markers of Inflammation? Monitoring and Treating Disorders with an Inflammatory Component using Fatty Acid Supplementation in Inhibition of Eicosanoid Production.”

  Association of Pathology Chairs Meeting, Boston, MA. July 2013. “Pathologist and Laboratory Diagnostic Algorithms: Increasing Overall Effectiveness in Improving Outcomes.”

  18th Annual Management Sciences and Patient Safety Leadership Seminar for the American Association for Clinical Chemistry, Houston, TX. July 2013. “Errors in Selection of Appropriate Laboratory Tests and Interpretation of Test Results: A Major Cause of Poor Patient Outcome.”

  Financial analysts briefing at the American Association of Clinical Chemistry national meeting. Houston, TX. July 2013. “The Role of the Laboratory and Controlling Health-care Spending.”

  Short course at the American Association of Clinical Chemistry national meeting. Enhancing Patient Safety, Reducing Diagnostic Errors and Improving Patient Care by Effective Utilization of Laboratory Testing. Houston, TX. July 2013. “The Essential Role of Interpretation and the Provision of Laboratory Services – How Can We do it Better?”

  Symposium at the national meeting for the American Association for Clinical Chemistry. Houston, TX. July 2013. “Optimizing Physicians Utilization of Laboratory Services for Better Patient Care.”

  First International Symposium on Personalized Medicine. Albert Einstein Hospital, Sao Paulo, Brazil. August 2013. “Making the Case for Pharmacogenomics Testing: Integration into a Healthcare System.”

  First International Symposium on Personalized Medicine. Albert Einstein Hospital, Sao Paulo, Brazil. August 2013. “Advising Clinicians on Laboratory Test Selection and Results Interpretation with a Diagnostic Management Team.”

  Keynote address, 47th Brazilian Congress on Clinical Pathology/Laboratory Medicine, São Paulo, Brazil. September 2013. “Medical Advice on the Application and Interpretation of Laboratory Tests: The Quality Starts Here.”

  47th Brazilian Congress on Clinical Pathology/Laboratory Medicine, São Paulo, Brazil. September 2013. “Pharmacogenomics in Clinical Practice: Lessons Learned from Coagulation.”

  College of American Pathologists National Meeting, Orlando, FL. October 2013. “Antiplatelet Agents and Anticoagulants.”

  New England Conference on Laboratory Medicine, Portland, ME. October 2013. “Errors in the Selection and Interpretation of Laboratory Tests: A Major Cause of Poor Patient Outcomes.”

  Aloha Chapter of Clinical Laboratory Management Association, Honolulu, HI. November 2013. “Optimizing Test Selection and Result Interpretation with Diagnostic Management Teams.”

  Keynote Address. Clinical Laboratory Management Association (CLMA) regional meeting, Nashville, TN. March 2014. “Errors in Selection of Appropriate Laboratory Tests and Interpretation of Test Results: A Major Cause of Poor Patient Outcome.”

  American Society for Clinical Laboratory Science, Kalamazoo, MI. April 2014. “The Diagnosis and Treatment of Hypercoagulable States.”

  American Society for Clinical Laboratory Science, Kalamazoo, MI. April 2014. “Laboratory Management of Anticoagulant Therapy.”

  Medical University of South Carolina Pathology Spring Symposia, Kiawah Island, SC. April 2014. “The Diagnosis and Treatment of Hypercoagulable States.”

  Keynote Address. American Society for Clinical Laboratory Science – Michigan, Kalamazoo, MI. April 2014. “Consultation in Laboratory Medicine.”

  19th Annual Executive War College, Conference on Laboratory in Pathology Management. New Orleans, LA. April 2014. “Diagnostic Management Teams and More at Vanderbilt: Moving Lab Medicine Closer to Physicians and Patients to Deliver More Value.”

  Medical University of South Carolina Pathology Spring Symposia. Kiawah Island, SC. April 2014. “The Diagnostic Management Team: Advising Clinicians on Laboratory Test Selection and Result Interpretation.”

  Pathology Informatics Summit 2014. Pittsburgh, PA. May 2014. “Errors in the Selection of Appropriate Laboratory Tests and Interpretation of Test Results: A Major Cause of Poor Patient Outcome.”

  Keynote Address. Clinical Laboratory Sciences Symposium, Montgomery, AL. June 2014. “New Role for Medical Laboratory Scientists: Advising Physicians on the Selection and Correct Interpretation of Laboratory Tests.”

  The Division of Animal Clinical Chemistry, 2014 Annual Meeting of the American Association of Clinical Chemistry, Chicago, IL. July 2014. “Anticoagulants: How They Work, How to Use Them, and How to Monitor Their Effects.”

  The American Association for Clinical Chemistry 2014 Annual Meeting, Chicago, IL. July 2014. “Antiplatelet Agents and Anticoagulants: Laboratory Monitoring.”

  Sunquest Users Group, Scottsdale, AZ, July 2014. “Development of a Consultative Service to Optimize Selection of Laboratory Tests and the Correct Interpretation of the Test Results: How are the Experts Linked into the Cases?”

  Sunquest Users Group, Scottsdale, AZ, July 2014. “Bringing the Diagnostic Expert to the Bedside: Role of Laboratory Testing and the Diagnostic Management Team.”

  The American Association for Clinical Chemistry 2014 Annual Meeting, Chicago, IL. July 2014. “Laboratory-associated Errors in Test Requests and Results Interpretation” (workshop titled “Diagnostic Errors and Patient Safety”).

  The American Society for Clinical Laboratory Sciences’ Leadership Meeting, Chicago, IL. July 2014. “Utilization of Clinical Laboratory Services in a World with New Rules: Overutilization, Underutilization and the Impact of Both on Patient Outcomes and Healthcare Costs.”

  The American Association for Clinical Chemistry 2014 Annual Meeting, Chicago, IL. July 2014. “Coordinated Care: The Academic Medical Center Experience” (workshop titled “Improving Laboratory Utilization and Accountable Care Organizations: A New Role for Laboratorians”).

  Diagnostic Error in Medicine 7th International Conference, Atlanta, GA. September 2014. Presentation in preconference workshop “Reducing Diagnostic Error through Improvement of Laboratory Test Utilization”.

  Diagnostic Error in Medicine 7th International Conference, Atlanta, GA. September 2014. “Understanding and Misunderstanding Diagnostic Testing: A Source of Diagnostic Error”.

  Keynote Address. 17th Annual Joint Meeting of the West Virginia Society for Clinical Laboratory Science and the West Virginia Clinical Laboratory Management Association, Charleston, WV. September 2014. “Diagnostic Management Team Approach to Advising Clinicians and Laboratorians on Laboratory Test Selection and Result Interpretation.”

  Association of Clinical Pathologists. Tampa, FL. October 2014. “Enhancing your Role in the Clinical Team.”

  International Conference on Laboratory Medicine. Clinical Laboratories: Navigating between Commoditization and Clinical Partnership. Padova, Italy. October 2014. “How to Optimize Laboratory Test Requests and Provide Patient Specific, Expert Driven Interpretations of Laboratory Test Results.”

  Keynote Address. AACC Texas Section Meeting, Tyler, TX. November 2014. “Utilization of Clinical Laboratory Services in a World with New Rules: Overutilization, Underutilization and the Impact of Both on Patient Outcomes and Healthcare Costs.”

  Texas Society of Pathologists, San Antonio, TX. January 2015. “Diagnostic Management Team: Approach to Advising Clinicians and Laboratorians on Laboratory Test Selection and Result Interpretation.”

  Keynote Address. Trainee Research Symposium. Baylor College of Medicine, Houston, TX. March 2015. “The World of Pathology in Your Career as a Pathologist: A New Set of Indispensable Duties.”

  Keynote Address. Lab Revolution. Orlando, FL. March 2015. “Building the Laboratory of the Future.” The American Association for Clinical Chemistry Industry Workshop, Atlanta, GA, July 2015. “Clinical and Economic Value of Antifactor Xa (Anti-XA) Monitoring in Patients Receiving Heparin.”

  The American Association for Clinical Chemistry 2015 Meeting, Atlanta, GA, July 2015. “Antiplatelet Agents and Anticoagulants: Laboratory Monitoring.”

  WASPALM Pathology and Laboratory Medicine: On the Forefront of Personalized Medicine. Cancun, Mexico. November 2015. “Coagulation: Diagnosis and Assays and Anticoagulants: The New Generation” and “Diagnostic Management Teams.”

  WASPALM Pathology and Laboratory Medicine: On the Forefront of Personalized Medicine. Cancun, Mexico. November 2015. “Diagnostic Management Teams.”

  Pathology and Lab Summit on Personalized and Precision Medicine. January 2016. “Diagnostic Error and Its Impact on Population Health.”

  Aurora Physician Symposium, Nashville, TN. April 2016. “Diagnostic Error in America: A Major Under-Recognized Problem Requiring Action by Pathologists and Laboratorians”.

  Michigan Society of Pathologists Annual Meeting, Lansing, MI. April 2016. “Institute of Medicine (IOM) Report “Improving Diagnosis in Health Care”

  Academy of Clinical Laboratory Physicians and Scientists, Birmingham, AL. June 2016. “Institute of Medicine (IOM) Report ‘Improving Diagnosis in Health Care’.”

  Diagnostic Error in Medicine, 1st European Conference, Rotterdam, the Netherlands. June 2016. “Diagnostic Management Teams.”

  Diagnostic Error in Medicine, 1st European Conference, Rotterdam, the Netherlands. June 2016. “Implications from the Institute of Medicine Report on Improving Diagnosis in Healthcare for the Laboratory Field.”

  Association of Pathology Chairs, San Diego, CA. July 2016. “Institute of Medicine (IOM) Report ‘Improving Diagnosis in Health Care.’”

  American Association of Clinical Chemistry, Philadelphia, PA. August 2016. “Anticoagulants: Indications and Laboratory Monitoring.”

  American Association of Clinical Chemistry, Philadelphia, PA. August 2016. “Diagnostic Errors: The Laboratory Viewpoint.”

  The American Society for Clinical Laboratory Science, Philadelphia, PA. August 2016. “Digging Deeper into the Institute of Medicine Report on Diagnostic Error.”

  Southern California Section of the AACC, Chino Hills, CA, November 2016. “Medical Errors: The Third Leading Cause of Death in the US.”

  Group for Research Pathology Education Conference, Orlando, Florida, January 2017. “The Role of Medical School Curricula in Advancing the Importance of Laboratory Medicine in Practice.”

  American Physician Scientist Association, Galveston, TX, January 2017. “Improving Diagnosis in Health Care with a Diagnostic Management Team.”

  The Compass Group, Columbus, OH, April 2017. The Ron Workman Memorial Lecture: "Medical Errors: The Third Leading Cause of Death in the US."

  Association of Clinical Scientists, Mountain Brook, AL, April 2017. “Practical Ways to Reduce Diagnostic Error: Clinical Pathology.”

  Association of Pathology Chairs, Washington, D.C., July 2017. “Underutilization from Diagnostic Errors: Understanding the Cost of Delayed Diagnosis.”

  Association of Pathology Chairs, Washington, D.C., July 2017. “Trials and Tribulations of New Leaders.”

  Intermountain States Seminar, Jackson, WY, September 2017. “Diagnostic Errors with Results We Generate: How to Stop Them from Occurring.”

  Intermountain States Seminar, Jackson, WY, September 2017. “The Worst Misdiagnosis of All: The Incorrect Diagnosis of Child Abuse.”

  Northeast Association of Pathology Chairs, Bermuda, September 2017. “Diagnostic Management Team: Moving Toward Widespread Implementation.”

  Society to Improve Diagnosis in Medicine, Boston, MA, October 2017. “The Diagnostic Management Team: Past, Present, and Future.”

  Annual Congress of Clinical Pathology, Puebla, Mexico, November 2017. “Expert Consultations at Everyone’s Bedside: The Work of the Diagnostic Management Team.”

  Annual Congress of Clinical Pathology, Puebla, Mexico, November 2017. “The Use of Direct Oral and Parenteral Anticoagulants to Prevent and Control Chronic Recurrent Thrombosis.”

  Virginia Society for Pathology. Richmond, VA, December 2017. “Diagnostic Management Team: Past, Present, and Future.”

  Diagnostic Management Team Conference, Galveston, TX, February 2018. “Diagnostic and Management Autopsy: Diagnostic Management Team Review of Diagnosis and Treatment after Death.”

  Diagnostic Management Team Conference, Galveston, TX, February 2018. “The Diagnostic Management Team 2018 and Beyond.”

  Diagnostic Management Team Conference, Galveston, TX, February 2018. “Appropriate Utilization of Laboratory Tests through a Diagnostic Management Team: Clinical and Financial Benefits.”

  Diagnostic Management Team Conference, Galveston, TX, February 2018. “Point-Counterpoint: If Diagnostic Management Teams Involve both Radiology and Pathology, should there be a Department of Diagnostics that Includes Both?”

  Diagnostic Management Team Conference, Galveston, TX, February 2018. “Step-by-step Guide: Setting up the Medical Logistics for Establishing a Diagnostic Management Team.”

  Clinical Laboratory Educators’ Conference, Houston, TX, February 2018. “The Diagnostic Management Team: A Solution for Diagnostic Error and Inappropriate Test Utilization.”

  Patient-centered Leadership and Front-line Quality Improvement Summit, Concord, NC, June 2018. “Clinical Excellence, Preventing Diagnostic Errors, and Cost Reduction through Better Lab Utilization.”

  Diagnostic Error in Medicine 11th International Conference, New Orleans, LA. November 2018. “The Diagnostic Management Team: Quality Improvement and Diagnostic Error Reduction.”

  Southeastern Administrators and Pathology Chairs Regional Conference, Amelia Island, FL. February 2019. “Pharmacogenomics: Who is in Charge?”

  Southeastern Administrators and Pathology Chairs Regional Conference, Amelia Island, FL. February 2019. “Diagnostic Management Team Development.”

  2019 Annual Symposium of the Puerto Rico Academy of Pathology and Laboratory Medicine, San Juan, Puerto Rico, April 2019. “The Diagnostic Management Team: Quality Improvement and Diagnostic Error Reduction.”

  2019 Annual Symposium of the Puerto Rico Academy of Pathology and Laboratory Medicine, San Juan, Puerto Rico, April 2019. “Obstacles to Widespread Implementation of Diagnostic Management Team Services.”

  2019 Annual Symposium of the Puerto Rico Academy of Pathology and Laboratory Medicine, San Juan, Puerto Rico, April 2019. “Pharmacogenomics: Who is in Charge? Is it Pathologists?”

  Texas Association for Clinical Laboratory Science 2019 Annual Meeting, Corpus Christi, TX, April 2019. “The Diagnostic Management team: Quality Improvement and Diagnostic Error Reduction.”

  AACC Professional Practice in Clinical Chemistry: The Clinical Laboratorian: Critical Member of the Healthcare Team, Dallas, TX, April 2019. “Becoming Indispensable by Meeting the Most Important Needs of Lab Users.”

  2019 Annual Meeting of the American Association of Clinical Chemistry, Anaheim, CA, August, 2019. “Clinical Chemistry Fellowship Training to Lead a Diagnostic Management Team.”

  2019 Annual Meeting of the American Association of Clinical Chemistry, Anaheim, CA, August, 2019. “Obstacles for Current Diagnostic Management Implementation.”

  Aurora Diagnostics/Sonic Healthcare Physician Symposium, Grapevine, TX. November 2019. “The Diagnostic Management team: Past, Present, and Future.”

  Organizer and Moderator, Association of Pathology Chairs Southeast Conference Annual Meeting, Cozumel, Mexico. February 2020.

• Invited Lectures - Off Campus

  The American Red Cross, St. Louis, MO. December 1983. "A Coenzyme A Synthetase Enzyme Specific for Icosanoid Precursor Fatty Acids."

  The Merck Institute for Therapeutic Research, Rahway, NJ. August 1985. "Mechanisms for Icosanoid Precursor Uptake and Release by a Tissue Culture Cell Line."

  The American Red Cross, Philadelphia, PA. April 1986. "The Diagnosis and Treatment of Coagulation Factor Deficiencies."

  The Lipid Club of Philadelphia, Philadelphia, PA. May 1986. "Control of Icosanoid Production at the Level of Arachidonoyl-CoA Synthesis."

  The Tissue Culture Association, Philadelphia, PA. May 1986. "The Reproducible Delipidation of Serum for Use in Tissue Culture."

  Washington University School of Medicine, St. Louis, MO. July 1987. "Control of Prostaglandin Production by Restriction of Exogenous Arachidonate."

  Hospital of the University of Pennsylvania, Philadelphia, PA. October 1987. Critical Care Medicine Symposium "Coagulation in the ICU."

  Case Western Reserve University School of Medicine, Cleveland, OH. January 1989. "The Availability of Cellular Arachidonate for Prostaglandin Production."

  Washington University School of Medicine, St. Louis, MO. February 1989. "Fatty Acid Acylation of Glycoprotein Ib and Glycoprotein IX in Human Platelets."

  Massachusetts General Hospital, Boston, MA. March 1989. "The Availability of Cellular Arachidonate for Prostaglandin Production."

  Thomas Jefferson University School of Medicine, Philadelphia, PA. April 1989. "Covalent Modification of Platelet Proteins by Palmitate."

  Washington University School of Medicine, St. Louis, MO. July 1987. "Control of Prostaglandin Production by Restriction of Exogenous Arachidonate."

  Philadelphia College of Osteopathic Medicine, Philadelphia, PA. March 1988. "Aspirin Ingestion and Myocardial Infarction."

  Case Western Reserve University School of Medicine, Cleveland, OH. January 1989. "The Availability of Cellular Arachidonate for Prostaglandin Production."

  Washington University School of Medicine, St. Louis, MO. February 1989. "Fatty Acid Acylation of Glycoprotein Ib and Glycoprotein IX in Human Platelets."

  Thomas Jefferson University School of Medicine, Philadelphia, PA. April 1989. "Covalent Modification of Platelet Proteins by Palmitate."

  Thrombosis Institute, Temple University School of Medicine, Philadelphia, PA. May 1989. "Covalent Modification of Platelet Proteins by Palmitate."

  University of Alabama, Birmingham, AL, August 1990. "The Availability of Cellular Arachidonate for Prostaglandin Production."

  Philadelphia College of Pharmacy and Science, Philadelphia, PA. November 1990. "Icosanoid Precursor Fatty Acid Metabolism."

  Massachusetts Association of Blood Banks, Waltham, MA. May 1991. "Acquired Hemostatic Defects."

  Ortho Pharmaceutical Corporation, Raritan, NJ. August 1991. "Clinical Coagulation Test Batteries."

  University Hospital of Debrecen, Hungary. September 1991. "Mechanisms of Fatty Acid Transport to Cells."

  Instrumentation Laboratories, Lexington, MA. December 1991. "Clinical Coagulation Test Batteries."

  Northeastern University, Boston, MA. March 1992. "Fatty Acids: Basic Biochemistry to Clinical Significance."

  T Cell Sciences, Cambridge, MA. July 1992. "Fatty Acid Ethyl Esters: A New Biochemical Marker for Alcoholism."

  New England Lipid Group, Boston, MA. September 1992. "Fatty Acid Ethyl Ester Metabolism."

  Basic Science Seminar Series, Tufts University School of Medicine, Boston, MA. January 1993. "Fatty Acid Modification of Proteins."

  Johns Hopkins University School of Medicine, Baltimore, MD. July 1993. "Fatty Acid Ethyl Esters: A Marker for Ethanol Ingestion."

  Department of Laboratory Medicine, University of Washington, Seattle, WA. December 1993. Visiting Professor.

  Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT. December 1993. "Training Residents in Clinical Pathology to be Effective Clinical Consultants."

  Department of Pathology, University of Vermont School of Medicine, Burlington, VT. January 1994. "Point of Care Testing."

  Department of Pathology, Cornell University School of Medicine, New York, NY. February 1994. "Establishing a Residency Program and Consult Service in Clinical Pathology."

  Department of Pathology, Duke University School of Medicine, Durham, NC. February 1994. "Alternate Site Laboratory Testing."

  Jefferson Medical College, Philadelphia, PA. May 1994. "Fatty Acid Ethyl Esters: Biochemistry to Clinical Significance."

  Massachusetts Society of Pathologists, Framingham, MA. May 1994. "Bedside Testing."

  New York Lipid Research Club, New York City, NY. September 1994. "The Covalent Modification of Platelet Proteins by Fatty Acids."

  Department of Pathology, Visiting Professor, Emory University School of Medicine, Atlanta, GA. October 1994. "Hypercoagulable States."

  Department of Pathology, Visiting Professor, Emory University School of Medicine, Atlanta, GA. October 1994. "Bedside Testing" and "Initiating a Consult Service in Clinical Pathology."

  Institute for Scientific Applications, Lyon, France. November 1994. "Fatty Acid Acylation of Platelet Proteins" and "Fatty Acid Ethyl Esters."

  Yale University School of Medicine, New Haven, CT. December 1994. "Fatty Acid Ethyl Esters: Toxic Metabolites of Ethanol."

  Department of Pathology, Visiting Professor, Albany Medical College, Albany, NY. January 1995. "Fatty Acid Ethyl Esters: New Markers for Ethanol Ingestion."

  Department of Pathology, Visiting Professor, Albany Medical College, Albany, NY. January 1995. "Development of a Clinical Pathology Consultation Service."

  Department of Pathology & Laboratory Medicine, Hahnemann University School of Medicine, Philadelphia, PA. March 1995. "Point of Care Testing."

  Baystate Medical Center (Affiliate of Tufts University School of Medicine), Springfield, MA. September 1995. "Fatty Acids: Biochemistry to Clinical Significance."

  Baystate Medical Center (Affiliate of Tufts University School of Medicine, Springfield, MA. September 1995. "Development of a Residency Training Program in Clinical Pathology."

  Division of Laboratory Medicine, Visiting Professor, Washington University School of Medicine, St. Louis, MO. April 1996. "The Development of the Clinical Consultation Service in Laboratory Medicine at the Massachusetts General Hospital."

  Division of Laboratory Medicine, Visiting Professor, Washington University School of Medicine, St. Louis, MO. April 1996. "Fatty Acid Ethyl Ester: A Toxic Nonoxidative Metabolic of Ethanol."

  Department of Welfare, Hungarian National Government, Budapest, Hungary. July 1996. "The Clinical Laboratory Inspection and Accreditation Process in the United States."

  Department of Gastroenterology, Warsaw Medical Academy, Warsaw, Poland. June 1996. "Fatty Acid Ethyl Esters: Toxic Nonoxidative Metabolites of Ethanol."

  Department of Gastroenterology, Warsaw Medical Academy, Warsaw, Poland. June 1996. "Hypercoagulable States."

  Medical University of Debrecen, Hungary. July 1996. "Fatty Acid Ethyl Esters: Toxic Nonoxidative Ethanol Metabolites."

  Department of Anesthesia, Beth Israel Hospital, Boston, MA. January 1997. "The Diagnosis of Commonly Encountered Coagulopathies."

  Department of Pathology, New York University, New York, NY. January 1997. "The Development of a Residency Training Program and Clinical Consultation Service in Clinical Pathology at Massachusetts General Hospital."

  Youville Rehabilitation Hospital, Cambridge, MA. February 1997. "Clinical Use and Monitoring of Low Molecular Weight Heparin."

  Biochemistry Colloquium Series. University of Massachusetts, Lowell, MA. March 1997. "Fatty Acid Ethyl Esters: New Markers for Ethanol Intake."

  Biochemistry Seminar Series, Chiron Diagnostics, Walpole, MA. March 1997. "Serum Fatty Acid Ethyl Esters: A New Indicator of Ethanol Intake."

  Laboratory Parameter Analysis Panel, Chicago, IL. March 1997. "Clinical Protocols and Laboratory Medicine."

  Massachusetts Society of Pathologists, Framingham, MA. April 1997. "Clinical Pathology - How to Do It and How to Get Paid for It."

  Northeastern University, Boston, MA. May 1997. "Trends in Laboratory Medicine."

  Penobscot Bay Medical Center, Rockland, ME. October 1997. "Coagulation Problems in the Community Hospital."

  Northeastern University Centennial Celebration, Boston, MA. November 1997. "The Future of Laboratory Medicine in an Era of Managed Care."

  Ball Memorial Hospital, Muncie, IN. March 1998. "Value Added Services in Clinical Laboratory Testing."

  Department of Pathology and Laboratory Medicine, Dartmouth Medical School, Hanover, NH. April 1998. "Value Added Clinical Laboratory Services: What the Clinicians Have Been Waiting For."

  Department of Medical Laboratory Sciences, University of New Hampshire, Durham, NH. April 1998. "Providing Clinicians with More than Just a Laboratory Test Result."

  Department of Pathology and Laboratory Medicine, Visiting Professor, University of Arizona School of the Health Sciences, Tucson, AZ. April 1998. "Clinical Laboratory Medicine: New Roles in Health Care."

  Department of Biophysics Seminar Series, Boston University School of Medicine, Boston, MA. January 1998. "Fatty Acid Ethyl Esters: A Missing Link in Ethanol Induced Organ Damage."

  University of Pennsylvania School of Medicine, Philadelphia, PA. February 1998. "Ethanol Metabolism & Innovations in Laboratory Medicine."

  University of Florida School of Medicine, Gainesville, FL. February 1998. "Ethanol Metabolism/Innovative Approaches to Diagnostic Testing."

  Ball Memorial Hospital, Visiting Professor, Muncie, IN. March 1998. "Fatty Acid Ethyl Esters: A New Marker for Ethanol Intake."

  Scientific Group on Obesity, Boston University School of Medicine, Boston, MA. March 1998. "Fatty Acid Ethyl Esters: Nonoxidative Ethanol Metabolites."

  Braintree Rehabilitation Hospital, Braintree, MA. March 1998. "The Clinical Indications for Use and Monitoring of Low Molecular Weight Heparin."

  Massachusetts Society of Pathologists, Worcester, MA. March 1998. "What the Pathologist Needs to Know about Coagulation Testing."

  University of North Carolina School of Medicine, Chapel Hill, NC. April 1998. "Ethanol Metabolism/Innovative Approaches to Diagnostic Testing."

  Department of Pathology and Laboratory Medicine, University of Arizona School of the Health Sciences, Visiting Professor, Tucson, AZ. April 1998. "Fatty Acid Ethyl Ester: A Toxic Ethanol Metabolite."

  Department of Surgery Grand Rounds, St. Elizabeth's Medical Center, Boston, MA. September 1998. "The Pharmacology of Low Molecular Weight Heparin."

  Department of Pathology, Ohio State University School of Medicine, Columbus, Ohio. September 1998. "Providing More than a Laboratory Test Result: A New Package of Value Added Services from the Clinical Laboratory." Deaconess-Glover Hospital Grand Rounds, Needham, MA. December 1998. "Commonly Encountered Problems in Coagulation."

  Department of Pathology, The Cleveland Clinic, Visiting Professor, Cleveland, OH. January 1999. "Interesting Coagulopathy Cases from the Massachusetts General Hospital."

  The Cleveland Clinic, Visiting Professor, Cleveland, OH. January 1999. "Fatty Acid Ethyl Esters in the Blood: A New Test for Ethanol Intake."

  Department of Pathology, The Cleveland Clinic, Visiting Professor, Cleveland, OH. January 1999. "The Value Added Clinical Laboratory Services at the Massachusetts General Hospital."

  Department of Pathology, The Cleveland Clinic, Visiting Professor, Cleveland, OH. January 1999. "The Development of the Laboratory Medicine Residency Training Program at the Massachusetts General Hospital."

  Department of Pathology, Thomas Jefferson University School of Medicine, Visiting Professor, Philadelphia, PA. January 1999. "Providing More than a Test Result: Redefining Expectations from the Clinical Laboratory."

  Department of Pathology, University of Texas Houston, Visiting Professor, Houston, TX. March 1999. “Narrative Interpretations in Laboratory Medicine.”

  Department of Pathology, University of Texas Houston, Visiting Professor, Houston, TX. March 1999. “Finding Your Place in the World of Pathology.”

  Department of Pathology, University of Texas Houston, Visiting Professor, Houston, TX. March 1999. “Laboratory Medicine Training at the Massachusetts General Hospital.”

  Department of Pathology, Penn State-Hershey Medical Center, Hershey, PA. April 1999. “The Value Added Clinical Laboratory Services at the Massachusetts General Hospital.”

  Department of Pathology, Berkshire Medical Center, Pittsfield, MA. April 1999. “Redefining Expectations from the Clinical Laboratory.”

  Current Issues in Vascular and Endovascular Surgery, Continuing Education Course, Harvard Medical School, Boston, MA. May 1999 and May 2000. “What the Vascular Surgeon Needs to Know about Coagulation Disorders and Anticoagulation Problems.”

  Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA. July 1999. “Redefining Expectations from the Clinical Laboratory.”

  Medical Grand Rounds, Faulkner Hospital, Boston, MA. August 1999. “The Clinical Indications and Laboratory Monitoring of Low Molecular Weight Heparin.”

  Grand Rounds, Harvard University Health Services, Cambridge, MA. September 1999. “The Diagnosis and Treatment of Hypercoagulable States.”

  Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA. September 1999. “The Value Added Clinical Laboratory Services at the Massachusetts General Hospital.”

  Medical Grand Rounds, HealthSouth New England Rehabilitation Hospital, Woburn, MA. September 1999. “The Clinical Indications and Laboratory Monitoring of Low Molecular Weight Heparin.”

  Vascular Surgery Grand Rounds, Massachusetts General Hospital, Boston, MA. September 1999. “Thrombosis in the Patient with a Hypercoagulable State.”

  Department of Pathology, UCLA School of Medicine, Los Angeles, CA. October 1999. “Re-defining Expectations from the Clinical Laboratory.”

  Kaiser Permanente Medical Group, Los Angeles, CA. October 1999. “The New Array of Services Provided by the Massachusetts General Hospital Clinical Laboratories.”

  Department of Pathology, UCLA School of Medicine, Los Angeles, CA. October 1999. “Hypercoagulable States: Diagnosis and Treatment.”

  Advances in Rheumatology, Continuing Education Course, Harvard Medical School, Boston, MA. October 1999 and September 2000. “Hypercoagulability Testing: Current Practice to Assess Thrombotic Risk.”

  Orthopedics Grand Rounds, Carney Hospital, Boston, MA. November 1999. “Low Molecular Weight Heparin: An Alternative to Unfractionated Heparin.”

  The Kessler Rehabilitation Institute, W. Orange, N.J. November 1999. “The Use and Monitoring of Low Molecular Weight Heparin.”

  Grand Rounds, Holy Family Hospital, Methuen, MA. November 1999. “The Diagnosis and Treatment of Hypercoagulable States.”

  Department of Pathology, St. Louis University School of Medicine, St. Louis, MO. January 2000. “The Hypercoagulable States.”

  Department of Pathology, St. Louis University School of Medicine, St. Louis, MO. January 2000. “Value Added Clinical Laboratory Services - A New Approach to Laboratory Medicine.”

  Pathology Education Institute, Snowmass, CO. February 2000. “Re-defining the Role of the Pathologist in the Clinical Laboratory.”

  Department of Pathology, University of South Florida School of Medicine, Tampa, FL. February 2000. “The Value Added Clinical Laboratory Services at the Massachusetts General Hospital.” Rheumatology Grand Rounds, Brigham and Women’s Hospital, Boston, MA. February 2000. “Diagnosis and Treatment of Hypercoagulable States.”

  The Food & Drug Administration, Tissue Engineering Course, Rockville, MD. February 2000. “Inflammation and Implantable Devices.”

  Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, CT. March 2000. “Establishing a Clinical Pathology Consultation Service.”

  Department of Pathology, Northwestern University School of Medicine, Chicago, IL. April 2000. “Redefining Laboratory Medicine.”

  Dade Behring Hemostasis Seminar Series, Boston, MA. April 2000. “Hypercoagulable States: Diagnosis and Treatment.”

  Department of Anesthesia Grand Rounds, Tufts/New England Medical Center, Boston, MA. April 2000. “Hypercoagulable States.”

  Vascular Biology Research Group, Tufts University School of Medicine, Boston, MA. May 2000. “Fatty Acid Ethyl Esters: Nonoxidative Ethanol Metabolites.”

  The Wagih Bari Society of St. Louis Pathologists, St. Louis, MO. September 2000. “The Nuts and Bolts of Operating an Interpretive Service in Clinical Pathology. The Regulations on Reflex Testing, Performing Interpretations, and Billing.”

  The Wagih Bari Society of St. Louis Pathologists, St. Louis, MO. September 2000. “The Value Added Clinical Pathology Services Provided at the Massachusetts General Hospital and a Glance into the Future.”

  The Wagih Bari Society of St. Louis Pathologists, St. Louis, MO. September 2000. “Diagnostic Errors in Coagulation with Catastrophic Outcomes.”

  The North Shore Medical Center/Salem Hospital, Salem, MA. October 2000. “Hypercoagulable States.”

  Harvard Medical School at the Millennium: What’s New and What’s Happening in and Around the Quadrangle, Boston, MA. October 2000. “Demonstration of a Web-Based System to Assist Physicians in the Selection and Interpretation of Laboratory Tests.”

  Baystate Medical Center, Update in Diagnostic Pathology and Medicine Series, Springfield, MA. November 2000. “The Value Added Clinical Laboratory Services at the Massachusetts General Hospital.”

  Brown University School of Medicine, Department of Surgery Grand Rounds, Providence, RI. November 2000. “Everything You Wanted to Know about Low Molecular Weight Heparin.”

  Newport Hospital, Newport, RI. November 2000. “New Markers for Hypercoagulable States.”

  Anna Jacques Medical Staff Grand Rounds, Newburyport, MA. January 2001. “Hypercoagulable States.”

  Department of Anesthesia Grand Rounds, Massachusetts General Hospital, Boston, MA. January 2001. “The Diagnosis and Treatment of Hypercoagulable States.”

  Distinguished Lecturer Series, Spaulding Rehabilitation Hospital, Boston, MA. January 2001. “Identification and Treatment of Hypercoagulable States.”

  Grand Rounds, Pathology Department, Massachusetts General Hospital, Boston, MA. January 2001. “Fatty Acid Ethyl Esters: Nonoxidative Ethanol Metabolites for Monitoring Ethanol Intake.”

  Johns Hopkins University School of Medicine, Distinguished Visiting Professorship of Pathology, Baltimore, MD. February 2001. “A Complete Redefinition of the Clinical Laboratory Service that Reduces Medical Error at the Massachusetts General Hospital.”

  Mt. Sinai Medical Center, Miami, FL. February 2001. “New Expectations from the Clinical Laboratory.”

  University of Miami School of Medicine, Miami, FL. February 2001. “Redefining the Services of the Clinical Laboratory.”

  Mt. Sinai Medical Center, Miami, FL. February 2001. “Genetic Markers of Hypercoagulability.”

  Rheumatology Grand Rounds, Massachusetts General Hospital, Boston, MA. March 2001. “The Appropriate Use of Low Molecular Weight Heparin.”

  Pharmacia Symposium for Healthcare Practitioners, Pittsburgh, PA. March 2001. “The Diagnosis and Treatment of Hypercoagulable States.”

  Mercy Hospital of Pittsburgh Medical Grand Rounds, Pittsburgh, PA. March 2001. “Low Molecular Weight Heparin.”

  Rheumatology Grand Rounds, Roger Williams Hospital of Brown University School of Medicine, Providence, RI. March 2001. “Hypercoagulability and the Antiphospholipid Syndrome.”

  The North Shore Medical Center/Salem Hospital, Salem, MA. April 2001. “von Willebrand’s Disease.”

  American Association of Clinical Chemistry, Review Course, Alexandria, VA. April 2001. “An Overview of Coagulation.”

  Vascular Surgery Grand Rounds, Massachusetts General Hospital, April 2001. “The New Anticoagulants.”

  Pulmonary Medicine Grand Rounds, SUNY Downstate Medical Center, Brooklyn, NY. May 2001. “Heritable Causes of Venous Thrombosis.”

  General Medicine Grand Rounds, Massachusetts General Hospital, September 2001. “Hypercoagulable States: Diagnosis, Treatment, and Controversies in Long Term Patient Management.”

  Transplantation Surgery Grand Rounds, Massachusetts General Hospital, September 2001. “Antiphospholipid Antibody Syndrome.”

  Obstetrics & Gynecology Grand Rounds, Massachusetts General Hospital, September 2001. “Thrombophilia: Obstetrical and Gynecologic Issues.”

  Grand Rounds, Memorial Sloane-Kettering Cancer Center, New York, NY. October 2001. “The Diagnosis and Treatment of Hypercoagulable States.”

  Surgery Grand Rounds, Massachusetts General Hospital, October 2001. “New Anticoagulants and Indications for Their Use.”

  Medical Grand Rounds, University of Massachusetts Memorial Medical Center, Worcester, MA. October 2001. “Sepsis, Anticoagulation, and a Drug That Connects Them.”

  Massachusetts General Hospital Special Seminar, October 2001. “Sepsis and Recombinant Activated Protein C.”

  University of Massachusetts Medical School, Worcester, Massachusetts. November 2001. “A Web-Based System for Patient-Specific Narrative Interpretations in Clinical Pathology.”

  Medical Grand Rounds, Allegheny General Hospital. December 2001. “Indications & Monitoring of Low Molecular Weight Heparin.”

  New England Medical Center, December 2001. “Inflammation, Coagulation, and a Drug that Connects the Two.”

  Merrimack Valley Hospital, Haverhill, MA. December 2001. “Anticoagulation with Warfarin and Heparin – Basic Principles.”

  Surgery Grand Rounds, Newton Wellesley Hospital, Newton, MA. January 2002. “DVT Prophylaxis and Treatment.”

  Emma Sadler Moss Lectureship, Louisiana State University Medical Center, February 2002. “Bleeding and Thrombotic Disorders.”

  Cardiac Surgery Grand Rounds, Massachusetts General Hospital, February 2002. “A Review of Hypercoagulable States.”

  Louisiana State University Medical Center, Department of Pathology, New Orleans, LA. February 2002. “A Complete Re-Definition of Services Provided by the Clinical Laboratory.”

  Roger Williams Hospital, Providence, RI. March 2002. “Low Molecular Weight Heparin.”

  Palisades Medical Center, North Bergen, NJ. March 2002. “A New Drug for Patients with Sepsis.”

  The MGH Child Psychiatry Section, Boston, MA. March 2002. “Omega-3 Fatty Acids and Attention Deficit Disorders.”

  Department of Pediatrics Cambridge Health Alliance and Mount Auburn Hospital, Cambridge, MA. May 2002. “Hypercoagulable States.”

  Lawrence Memorial Hospital, Visiting Clinician Program, Medford, MA, June 2002. “The Hypercoagulable State.”

  Massachusetts General Hospital, Department of Neurology, June 2002. “Hypercoagulable States.”

  Cambridge Hospital, Department of Surgery Grand Rounds, June 2002. “Low Molecular Weight Heparin.”

  Exeter Hospital, Grand Rounds, Exeter, NH. June 2002. “The Diagnosis and Treatment of Hypercoagulable States.”

  Neurosurgery Grand Round, Massachusetts General Hospital, July 2002. “Hypercoagulable States.”

  Hematology-Oncology Grand Rounds, New York Hospital/Cornell Medical College, New York, NY. September 2002. “The Use of Low Molecular Weight Heparin.”

  Rhode Island Blood Bankers Society, Providence, RI, September 2002. “Factor VIII Inhibitors: Diagnosis and Treatment.”

  Neuro-Oncology Grand Rounds, Massachusetts General Hospital, September 2002. “The Use of Low Molecular Weight Heparin and Fondaparinux as Prophylaxis for Venous Thrombosis.”

  Podiatry Grand Rounds, Massachusetts General Hospital, September 2002. “Deep Vein Thrombosis: Prophylaxis and Treatment.”

  Cancer Medicine and Hematology, Harvard Medical School Continuing Education Course, September 2002. “Case Management Problems in Coagulation.”

  Surgery Grand Rounds, Mt. Auburn Hospital, Cambridge, MA. October 2002. “Low Molecular Weight Heparin: Indications and Monitoring.”

  University of Hawaii Pathology Residency Program, Honolulu, HI. October 2002. “Hypercoagulable States: Diagnosis and Treatment.”

  University of Texas at San Antonio, San Antonio, TX. November 2002. “Redefining Expectations from the Clinical Laboratory.”

  North Shore Medical Center, Grand Rounds, Salem, MA. November 2002. “The Diagnosis and Treatment of Hypercoagulable States.”

  Spaulding Rehabilitation Hospital, Boston, MA. November 2002. “New Anticoagulants.”

  Medical Grand Rounds, Massachusetts General Hospital, December 2002. “DVT Prophylaxis and Treatment in 1978: When I Was a Caveman Clotter.”

  St. Francis Hospital and Medical Center/University of Connecticut. Medical Grand Rounds, Hartford, CT. January 2003. “Clinical and Laboratory Approach to Thrombophilia.”

  The 4th Annual Frank M. Townsend Lecture, University of Texas at San Antonio, San Antonio, TX. November 2002. “Fatty Acid Ethyl Esters: Toxic Nonoxidative Ethanol Metabolites.”

  Gastroenterology Research Seminar, University of Pennsylvania School of Medicine, Philadelphia, PA. January 2003. “Fatty Acid Ethyl Esters.”

  Pathology Grand Rounds, University of Pennsylvania School of Medicine, Philadelphia, PA. January 2003. “Fatty Acid Ethyl Ester: A Toxic Nonoxidative Ethanol Metabolite.”

  Pathology Continuing Education Program, St. Francis Hospital, Hartford, CT. January 2003. “Laboratory Testing for Thrombophilia.”

  Rheumatology Grand Rounds, Beth Israel Deaconess Hospital, Boston, MA. January 2003. “Hypercoagulable States.”

  Neurology Grand Rounds, Lahey Clinic, Burlington, MA. January 2003. “Diagnosis and Treatment of Hypercoagulable States.”

  Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia, PA. January 2003. “Redefining Expectations from the Clinical Laboratory.”

  Connecticut Society of Pathologists, New Haven, CT. January 2003. “Clinical and Laboratory Approach to Thrombotic Disorders.”

  Connecticut Society of Pathologists, New Haven, CT. January 2003. “Establishing a Fee for Service Clinical Pathology Consultation Service.”

  2nd Year Louisiana State University Medical Student Lecture, New Orleans, LA. February 2003. “A Review of Hemostasis.”

  Department of Pathology, Louisiana State University School of Medicine, New Orleans, LA. February 2003. “Fatty Acid Ethyl Esters: How Much Ethanol is Good or Bad?”

  Department of Anesthesia Didactic Course, Massachusetts General Hospital, Boston, MA. February 2003. “Why Doesn’t the Blood Clot?”

  Cedars-Sinai Hospital Grand Rounds, Miami, FL. February 2003. “Inflammation, Coagulation, and a Drug that Connects the Two.”

  Massachusetts General Hospital, Pathology Grand Rounds, Boston, MA. February 2003. “Fatty Acid Alterations in Cystic Fibrosis.”

  Sylvester Cancer Center, University of Miami, Miami, FL. February 2003. “The Mechanism of Action of Recombinant Activated Protein C.”

  Lowell General Hospital Grand Rounds, Lowell, MA. February 2003. “The Diagnosis and Treatment of Hypercoagulable States.”

  Department of Pathology, Baylor University School of Medicine, Houston, TX. March 2003. “Redefining Expectations from the Clinical Laboratory.”

  Texas Children’s Hospital Grand Rounds Hematology – Oncology. Houston, TX. March 2003. “Hypercoagulable States and Their Association with Malignancy.”

  Dana Farber Cancer Institute, Boston, MA. April 2003. “An Overview of Fatty Acid Metabolism and its Implications for Anti-Cancer Treatment.”

  ASCP Resident Review Course, Hoffman Estates, IL. April 2003. “Coagulation Overview.”

  Professional Practice in Clinical Chemistry: A Review and Update, Arlington, VA. April 2003. “An Overview of Bleeding and Thrombotic Disorders.”

  Updates in Anesthesia, Boston, MA. May 2003. “Why Doesn’t the Blood Clot?”

  Conemaugh Valley Memorial Hospital, Johnstown, PA. May 2003. “Ethanol: The Good and the Bad.”

  New Frontiers in Vascular and Endovascular Surgery, Boston, MA. May 2003. “What Surgeons Should know about New Heparins and Hypercoagulability.”

  Conemaugh Valley Memorial Hospital, Johnstown, PA. May 2003. “Hypercoagulable States.”

  North Shore University Hospital, Forest Hills, NY. May 2003. “Low Molecular Weight Heparin: Prophylaxis and Treatment of DVT and PE.”

  Conemaugh Valley Memorial Hospital, Johnstown, PA. May 2003. “Redefining Clinical Laboratory Services.”

  Windham Hospital Grand Rounds, Willamantic, CT. June 2003. “Diagnosis and Treatment of Hypercoagulable States.”

  Current Concepts in Clinical Pathology, Boston, MA. June 2003. “Whom to Monitor for Hypercoagulability – Report of the CAP Consensus Conference on Thrombophilia Testing” and “Common Errors in Coagulation.”

  Current Concepts in Clinical Pathology, Boston, MA. June 2003. “Lipid Testing and the Prediction of Cardiovascular Risk.”

  Federal Government Laboratorians Seminar (sponsored by Roche). July 2003. National Liberty Museum, Philadelphia, PA. “Reducing Medical Errors by Providing Expert Advice in the Selection and Interpretation of Laboratory Tests.”

  Memorial Sloane Kettering Cancer Center, New York City, NY. July 2003. “Fatty Acid Ethyl Esters: Toxic Nonoxidative Ethanol Metabolites.”

  A Comprehensive Board Review in Hematology and Medical Oncology, Houston, TX. October 2003. “Hypercoagulable States.”

  Centers for Disease Control (CDC) Executive Session on the formation of the Quality Institute for Laboratory Medicine, Atlanta, GA. December 2003. “Quality Enhancement of Clinical Laboratory Services – An External Perspective on the Issues.”

  Ospedale Pediatrico Bambina Gesu, Rome, Italy. December 2003. “Fatty Acid Alterations in Cystic Fibrosis.”

  Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY. Visiting Professor. January 2004. “Diagnosis and Treatment of Hypercoagulable States.”

  Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY. January 2004. Visiting Professor. “Finding Your Place in the World of Pathology.”

  Basic Science Lecture Series, University of Texas Medical Branch, Galveston, TX. March 2004. “Fatty Acid Ethyl Esters: Nonoxidative Metabolites of Ethanol.”

  Anesthesia Grand Rounds, Newton-Wellesley Hospital, Newton, MA. March 2004. “Anticoagulants Old and New”.

  Newport Hospital Grand Rounds, Newport, RI. March 2004. “What is New & Old in Anticoagulation.”

  Department of Pathology Visiting Professor Lecture Series, University of Alabama at Birmingham, Birmingham, AL. March 2004. “Fatty Acid Ethyl Esters: Toxic Nonoxidative Ethanol Metabolites.”

  Department of Pathology, University of Alabama at Birmingham, Birmingham, AL. March 2004. “Finding your Place in the World of Pathology.”

  Cedars-Sinai Hospital, Visiting Professor Los Angeles, CA. April 2004. “The Diagnosis & Treatment of Hypercoagulable States.”

  ASCP Resident Review Course, Hoffman Estates, IL. April 2004. “Coagulation.”

  Cedars-Sinai Hospital, Visiting Professor, Los Angeles, CA. April 2004. “Finding Your Place in the World of Pathology.”

  Cedars-Sinai Hospital, Visiting Professor, Los Angeles, CA. April 2004. “Redefining Clinical Laboratory Services for Improved Patient Safety.”

  Instrumentation Laboratories International Advisory Board, Cambridge, MA. April 2004. “The Added Value of Patient-Specific Narrative Interpretations.”

  Department of Pathology, University of Texas, Houston, TX. May 2004. “Finding Your Place in the World of Pathology.”

  Department of Pathology, University of Texas, Houston, TX. May 2004. “Value Added Services in Clinical Pathology.”

  Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada. June 2004. “Patient Safety: Have We Overlooked Errors in Test Selection and Interpretation of Laboratory Tests?”

  University of Rome, Department of Experimental Medicine and Pathology, Rome, Italy. June 2004. “The Diagnosis and Treatment of Hypercoagulable States.”

  Westerly Hospital Grand Rounds, Westerly, RI. September 2004. “Anticoagulants and Thrombosis Prevention.”

  South County Hospital Grand Rounds, Wakefield, RI. September 2004. “Anticoagulants: An Overview” and “Heparin-Induced Thrombocytopenia.”

  Cancer Medicine and Hematology, Harvard Medical School Continuing Education Course, September 2004. “Case Management Problems in Coagulation.”

  Update in Hemostasis and Thrombosis, Lehigh Valley Hospital, Allentown, PA. October 2004. “The Diagnosis and Treatment of Hypercoagulable States.”

  Michigan Society of Pathologists Winter Seminar, Ann Arbor, MI. December 2004. “Coagulation in the Clinical Laboratory.”

  Tufts University School of Medicine, MD-PhD Research Seminar Series, Boston, MA. January 2005. “Fatty Acid Ethyl Esters.”

  Children’s Memorial Hospital (The pediatrics hospital for Northwestern University Medical Center), Grand Rounds, Chicago, IL. March 2005. “Coagulation Disorders in Children.”

  Emerson Hospital Grand Rounds, Concord, MA. April 2005. “Anticoagulants: Indications and Monitoring.”

  Spaulding Rehabilitation Hospital, Grand Rounds. “Heparin-Induced Thrombocytopenia: Diagnosis and Treatment with Argatroban.” Boston, MA. April 2005

  The Knight Nursing Center for Clinical and Professional Development, Boston, MA. May 2005. “The Causes and Common Bleeding and Clotting Disorders and What to Do About Them.”

  Professional Practice in Clinical Chemistry: A Review and Update, Arlington, VA. May 2005. “An Overview of Bleeding and Thrombotic Disorders.”

  ASCP Resident Review Course, Hoffman Estates, IL. May 2005. “Coagulation.”

  J. Heinrich Joist First Memorial Lecture, St. Louis, MO. September 2005. “Hypercoagulable States: Diagnosis and Treatment.”

  Comprehensive Update on Vascular Disease for the Primary Care and Specialty Provider, Waltham, MA. November 2005. “Hypercoagulable States: Update on How, Who, and When to Screen.”

  Lahey Clinic Surgery Grand Rounds. Burlington, MA. January 2006. “An Overview of Coagulation for the Surgeon.”

  Brigham and Women’s Hospital, Division of Rheumatology. Boston, MA. January 2006. “Antiphospholipid Antibodies: What They Are and What They Do.”

  Beth Israel Deaconess Medical Center, Division of Rheumatology, Boston, MA. March 2006. “Antiphospholipid Antibodies and Antiphospholipid Syndrome: Description, Diagnosis, and Treatment.”

  Tufts/New England Medical Center, Department of Pathology, Boston, MA. March 2006. “Value Added Services in Laboratory Medicine.”

  The Hemostasis Scientific Advisory Committee 2006 Meeting, Instrumentation Laboratory, Lexington, MA. April 2006. “Point of Care Coagulation Testing: What Assays Could Move Out of the Main Laboratory and Institutional Factors Which Influence that Decision.”

  Clinical Laboratory Improvements Act Committee Meeting, Atlanta, GA. September 2006. “Narrative Interpretations of Complex Clinical Laboratory Evaluations”.

  Commencement address, Medical Professional Institute, Malden, MA. September 2006.

  In Vein Treatment and Techniques, Las Vegas, NV. October 2006. “Hypercoagulable States: A Primer for Office Management.”

  Life After a Heart Attack: A Lecture for Community Health Awareness (for the public). Malden, MA. November 2006.

  Visiting Professor, Ball Memorial Hospital, Department of Pathology, Muncie, IN. December 2006. “Value-Added Services in Laboratory Medicine” and “Finding Your Place in the World of Pathology: Mentorship for Residents.”

  Visiting Professor, Ball Memorial Hospital, Department of Pathology, Muncie, IN. December 2006. “An Overview of Thrombotic and Bleeding Disorders.”

  Melrose-Wakefield Hospital Grand Rounds, Malden, MA. January 2007. “Hypercoagulable States, Anticoagulants, and Heparin-Induced Thrombocytopenia”.

  Visiting Professor, Case Western University Medical Center, Department of Pathology, Cleveland, OH. January 2007. “Patient-Specific Expert Driven Narratives in Clinical Pathology – It’s Time Has Come” and “Finding Your Place in the World of Pathology”.

  Case Western Reserve University Medical Center, Department of Pathology, Visiting Professor, Cleveland, OH. January 2007. “Fatty Acid Alterations in Cystic Fibrosis – Moving beyond the Original Biochemical Observations and Understanding the Basis of the DHA Therapeutic Effect”.

  Youville Rehabilitation Hospital, Grand Rounds, Cambridge, MA. February 2007. “The Management of Venous Thromboembolic Disease.”

  Cedar-Sinai Medical Center Grand Rounds, Los Angeles, CA. February 2007. “The Diagnosis and Treatment of Hypercoagulable States.”

  Evergreen Hospital Grand Rounds, Seattle, WA. February 2007. “The Diagnosis and Treatment of Hypercoagulable States.”

  University of Rome (La Sapienza), School of Medicine. Lecture to Medical Students. Rome, Italy. March 2007. “An Overview of Hemostasis

  University Palermo, School of Medicine. Palermo, Italy. March 2007. “Value Added Services in Clinical Pathology: A New Role for the Clinical Pathologist.”

  Temple University School of Medicine, Department of Pathology. Philadelphia, PA. April 2007. “Cystic Fibrosis: Fatty Acid Alterations and Fatty Acid Supplementation.”

  Vanderbilt University School of Medicine, Department of Pathology. Nashville, TN. April 2007. “Fatty Acid Alterations in Cystic Fibrosis: A Target for Therapy.”

  Professional Practice in Clinical Chemistry: A Review and Update. Washington, DC. April 2007. “Coagulation.”

  ASCP Resident Review Course, Director of Laboratory Medicine Section and Lecturer. Chicago, IL. April 2007. “An Overview of Coagulation.”

  The Annual Israel Michaelson Distinguished Lectureship, The University of Tennessee Health Science Center, Department of Pathology and Laboratory Medicine, Memphis, TN. June 2007. “What We Really Need to be Doing as Pathologists in Laboratory Medicine.”

  In Vein: Treatment and Techniques. Uncasville, CT. April 2007. “What Do I Really Need to Know About Hypercoagulable States.” and “How to Evaluate the Patient with Idiopathic DVT.” Hackensack University Medical Center, Surgery Grand Rounds, Hackensack, NJ. October 2007. “Coagulation for the Surgeon.”

  UCLA Medical Center, Department of Pathology Grand Rounds, Los Angeles, CA. October 2007. “Providing Patient-Specific Narrative Reports for Complex Clinical Laboratory Evaluations: Why Can’t We Do What the Radiologists and Anatomic Pathologists Do?”

  Loyola University School of Medicine, Pathology Grand Rounds, Chicago, IL. January 2008. “Cystic Fibrosis”.

  ASCP Resident Review Course, Director of Laboratory Medicine Section and Lecturer. Chicago, IL. April 2008. “An Overview of Coagulation.”

  Department of Medicine Grand Rounds, University of Alabama at Birmingham, Birmingham, AL. September 2008. “The Use and Monitoring of Anticoagulants”.

  Department of Pathology, University of Texas - San Antonio. Visiting Professor, San Antonio, TX. February 2009. “The Appropriate Use and Laboratory Monitoring of Anticoagulants.”

  Cleveland Clinic, Pathology Grand Rounds as Visiting Professor, Cleveland, OH. March 2009. “Reshaping Laboratory Medicine.”

  ASCP Resident Review Course, Director of Laboratory Medicine Section and Lecturer. Chicago, IL. April 2009. “An Overview of Coagulation.”

  Anesthesia Review and Update, Harvard Continuing Medical Education Symposium, Boston, MA. May 2009. “Why Doesn’t the Blood Clot?” and “Why Does the Blood Keep Clotting?”

  Visiting Professor, Ball Memorial Hospital, Department of Pathology, Muncie, IN. January 2010. “Hypercoagulable States: Diagnosis and Treatment”

  Visiting Professor, Ball Memorial Hospital, Department of Pathology, Muncie, IN. January 2010. “Anticoagulants: Clinical Indications and Monitoring”

  Visiting Professor, Ball Memorial Hospital, Department of Pathology, Muncie, IN. January 2010. “The Rapid Transformation of Diagnostic Services and the Creation of the Diagnostic Management Team.”

  Visiting Professor, St. Francis Hospital, Medical Grand Rounds, Hartford, CT. February 2010. “Cost Effective Strategies for Clinical Laboratory Testing.”

  Tennessee Donor Services Medical Advisory Committee, Nashville, TN. April 2010. “Disseminated Intravascular Coagulation in the Transplant Patient.”

  ASCP Resident Review Course, Director of Laboratory Medicine Section and Lecturer. Chicago, IL. April 2010. “An Overview of Coagulation.”

  Harvard Anesthesia Update 2010, Boston, MA. May 2010. “Why Doesn’t the Blood Clot?” and “Why Does the Blood Keep Clotting?

  Visiting Professor, University of Illinois at Champaign-Urbana, Champaign, IL. November 2010. “Fatty Acids: Metabolism and Clinical Significance.”

  University of South Florida, Pathology Grand Rounds, Tampa, FL. January 2011. “Case Studies in Laboratory Management: Coagulation Disorders.”

  Clinical Laboratory Improvements Act Advisory Committee (CLIAC) Meeting, Atlanta, GA. March 2011. “Update on the activities of the Clinical Laboratory Integration into HealthCare Collaborative.”

  ASCP Resident Review Course, Director of Laboratory Medicine Section and Lecturer. Chicago, IL. April 2011. “An Overview of Coagulation.”

  Harvard Anesthesia Update 2011, Boston, MA. May 2011. “Why Doesn’t the Blood Clot?” and “Why Does the Blood Keep Clotting?”

  Visiting Professor, McGill University, Montreal, Canada. November 2011. “Fatty Acid Abnormalities in Cystic Fibrosis.”

  Yale University School of Medicine, Department of Laboratory Medicine, Visiting Professor. January 2012. “Improving Test Selection and Test Result Interpretation.”

  ASCP Resident Review Course, Tampa, FL. February 2012. “Coagulation”

  Department of Anesthesiology, Tufts University School of Medicine, Boston, MA. May 2012. “Anticoagulant and Antiplatelet Therapy: The New and the Old.”

  Harvard Anesthesiology Update, Boston, MA. May 2012. “Anticoagulants: The Old and the New” and “New Antiplatelet Agents.” The Massachusetts Society of Pathologists, Waltham, MA. May 2012. “Advising Physicians on the Selection and Interpretation of Clinical Laboratory Tests: The Diagnostic Management Team at Vanderbilt.”

  Anesthesia Grand Rounds, Beth Israel Deaconess Hospital, Boston, MA. August 2012. “New Anticoagulants and New Anti-Platelet Agents: What are the Surgical Bleeding Risks?”

  University of Washington, Laboratory Medicine Grand Rounds. Seattle, WA. November 2012. “Advising Clinicians on Laboratory Test Selection and Result Interpretation with a Diagnostic Management Team.”

  University of Utah and ARUP Grand Rounds, Salt Lake City, UT. November 2012. “Advising Clinicians on Laboratory Test Selection and result Interpretation with a Diagnostic Management Team.”

  Glenwood Regional Medical Center, Monroe, LA. February 2013. “Anticoagulants and Antiplatelet Agents’ and “The Diagnosis and Treatment of Coagulation Disorders.”

  Visiting Professor, Department of Pathology, Beth Israel Hospital, Boston, MA. March 2013. “Advising Clinicians on Laboratory Test Selection and Results Interpretation with a Diagnostic Management Team.”

  Baylor College of Medicine, Pathology and Immunology Grand Rounds, Houston, TX. March 2013. “Advising Clinicians on Laboratory Test Selection and Results Interpretation with a Diagnostic Management Team.”

  Hospital Grand Rounds, Altura Hospital, Grand Forks, ND. April 2013. “Beyond the Clot: The Diagnosis and Treatment of Hypercoagulable States.”

  Northwestern University School of Medicine, Pathology Department Rounds. Chicago, IL. May 2013. “Advising Clinicians on Laboratory Test Selection and Results Interpretation with a Diagnostic Management Team.”

  McMaster University Department of Pathology and Molecular Medicine. Keynote address at Annual Residents Research Day, 2013. Hamilton, Ontario, Canada. May 2013. “Advising Clinicians on Laboratory Test Selection and Result Interpretation with the Diagnostic Management Team.’

  University of Illinois at Chicago, Pathology Department Grand Rounds, Chicago IL. June 2013. “Advising Clinicians on Laboratory Test Selection and Result Interpretation with the Diagnostic Management Team.”

  Mount Sinai Hospital, Miami, FL. June 2013. A series of 7 lectures on a wide variety of topics in diagnostic coagulation.

  Webinar for ADVANCE, June 2013. “Advising Clinicians on Laboratory Test Selection and Result Interpretation with the Diagnostic Management Team.”

  Visiting Professor, Department of Pathology, University of Miami, Miami FL. October 2013. “Errors in the Selection and Interpretation of Laboratory Tests: A Major Cause of Poor Patient Outcome.”

  Grand Rounds, Tripler Army Hospital, Honolulu, HI. November 2013. “Consultation to Optimize Clinical Laboratory Test Selection and Result Interpretation.”

  St. Jude Children’s Hospital, ASCLS sponsored presentation. Memphis, TN. December 2013. “Errors in Selection of Appropriate Laboratory Tests and Interpretation of Test Results: A Major Cause of Poor Patient Outcome.”

  Visiting Professor, Department of Pathology Grand Rounds. Temple University School of Medicine, Philadelphia, PA. January 2014. “Advising Clinicians and Laboratorians on Lab Test Selection: The Diagnostic Management Team.”

  Visiting Professor, Department of Pathology Grand Rounds, University of Massachusetts, Worcester, MA. February 2014. “Advising Clinicians and Laboratorians on Lab Test Selection: The Diagnostic Management Team.”

  Visiting Professor, Department of Pathology Grand Rounds, Cleveland Clinic, Cleveland, OH. February 2014. “Errors in Selection of Appropriate Laboratory Tests and Interpretation of Test Results: A Major Cause of Poor Patient Outcome.”

  Visiting Professor, Department of Pathology Grand Rounds. University of Florida, Gainesville, FL. March 2014. “The Diagnostic Management Team: Advising Clinicians on Laboratory Test Selection and Interpretation.”

  Laboratory Management Series. UT Southwestern Medical Center, Dallas, TX. February 2015. “The Indispensable Pathologist: Leader of a Diagnostic Management Team.”

  Pathology Grand Rounds. Virginia Commonwealth University. Richmond, VA. March 2015. “The Diagnostic Management Team: The Missing Link in Healthcare in the United States.”

  Sunquest Information Systems User Group Conference. Phoenix, AZ, July 2015. “How Sunquest Can Reduce Diagnostic Errors and Dramatically Reduce Healthcare Costs.”

  AACC Webinar. August 2015. “Utilization of Clinical Laboratory Services in a World with New Rules: Overutilization, Underutilization and the Impact of Both on Patient Outcomes and Healthcare Costs”.

  ASCP Live Webcast. September 2015. “Diagnostic Errors and the Impact on Patient Outcome and Healthcare Costs.”

  Division of Pathology and Laboratory Medicine’s Grand Rounds. MD Anderson Cancer Center. Houston, TX, September 2015. “The Diagnostic Management Team: A New Approach to Consultation by Pathologists.”

  Clinical and Scientific Advances Series. University of California at Irvine. Irvine, CA. September 2015. “The Diagnostic Management Team: A New Approach to Consultation by Pathologists.”

  2015-2016 Daljit S. and Elaine Sarkaria Lecture. First Annual Clinical Innovation/Quality Day. University of California at Los Angeles. Los Angeles, CA. September 2015. “Reducing Diagnostic Error: A Critical Role for the Pathologist.”

  Pathology Grand Rounds. Stanford University, Stanford, CA. November 2015. “Reducing Diagnostic Error: A Critical Role for the Pathologist.” Clinical Diagnostics Research Webinar sponsored by Lab Roots. November 2015. “Optimizing the Use of Laboratory Testing Services to Improve Patient Diagnosis.”

  Laboratory Medicine Grand Rounds. Memorial Sloan-Kettering Cancer Center, New York, NY. February 2016. “Diagnostic Error in America: A Major Under-recognized Problem Requiring Laboratorians to Fix It.”

  Laboratory Medicine Grand Rounds. Washington University in St. Louis School of Medicine, St. Louis, MO. March 2016. “The Institute of Medicine (IOM) Report: Improving Diagnosis in Healthcare”.

  University Medical Center, Utrecht, the Netherlands. June 2016. “Utilization of Clinical Laboratory Services in a World with New Rule: Overutilization, Underutilization and the Impact of Both on Patient Outcomes and Healthcare Costs”.

  Department of Pathology and Laboratory Medicine Grand Rounds, University of Pennsylvania, Philadelphia, PA, September 2016. “Medical Errors: The Third Leading Cause of Death in the US.”

  Southern Dean’s Annual Meeting, San Antonio, TX, October 2016. “Medical Errors: The Third Leading Cause of Death in the US.”

  SmartLab Annual Meeting, San Antonio, TX, October 2016. “How to Avoid Commonly Encountered Errors in the Clinical Laboratory.”

  SmartLab Annual Meeting, San Antonio, TX, October 2016. “A Team Approach to Diagnostic Management Concierge Care: The Health Model of the Future.”

  X Congreso Nacional del Laboratorio Clinico, Zaragoza, Spain. October 2016. “Improving Diagnosis in Health Care with a Diagnostic Management Team.”

  Terplan Lecture, University of Buffalo, Buffalo, NY, October 2016. “Medical Errors: The Third Leading Cause of Death in the US.”

  Department of Medicine Medical Grand Rounds, St. Michael’s Hospital, Toronto, Ontario, Canada. December 2016. “Medical Errors: The Third Leading Cause of Death in the US”.

  Diagnostic Management Team Conference. Galveston Convention Center, Galveston, TX. February 2017. “The Diagnostic Management Team: Past, Present and Future.”

  Benjamin Highman Lecture, University of California, Davis. March 2017. “Medical Errors: The Third Leading Cause of Death in the US.”

  Milka M. Montiel Lecture, UT Health San Antonio, TX. April 2017. “Implications from the National Academy of Medicine Report on Improving Diagnosis in Healthcare.”

  AACC Webinar, May 2017. “Diagnostic Errors: The Laboratory Viewpoint.”

  Lab Leaders Summit, August 2017, Indianapolis, IN. “The Clinical and Financial Benefits of a Diagnostic Management Team.”

  Pathology Grand Rounds, University of Alabama at Birmingham, AL. October 2017. “Medical Errors: The Third Leading Cause of Death in the US.”

  Robert V.P. Hutter Endowed Lectureship, SUNY Upstate Medical University, Syracuse, NY. November 2017. “Diagnostic Management Team: Moving Toward Widespread Implementation.”

  Faculty Mini Retreat, SUNY Upstate Medical University, Syracuse, NY. November 2017. “What is CP and How Do We Treat our Residents to Do It.”

  Faculty Interest Group, SUNY, Syracuse, NY. November 2017. “Medical Errors: The Third Leading Cause of Death in the US.”

  Surgery Grand Rounds, Texas Children’s Hospital. December 2017. “Medical Errors: The Third Leading Cause of Death in the US.”

  Department of Pathology and Laboratory Medicine Grand Rounds, Cedars-Sinai Medical Center, July 2018. “Increasing Impact of the Diagnostic Management Team.”

  Department of Pathology and Laboratory Medicine Education Seminar, Cedars-Sinai Medical Center, July 2018. “Step-by-Step Guide: Detailed Logistics for Establishing a Diagnostic Management Team.”

  Baylor Pathology Citywide Grand Rounds, Baylor College of Medicine, Houston, Texas, August 2018. “The Worst Misdiagnosis of All: The Incorrect Diagnosis of Child Abuse.”

  College of American Pathologists/American Hospital Association Webinar, September 2018. “The Importance of Forming a Diagnostic Management Team: Strategies to Reduce Costs and Improve Patient Outcomes.”

  Doctoral Seminar Experience, Texas Tech University, Lubbock, Texas, September 2018. “Increasing Impact of the Diagnostic Management Team.”

  Texas Tech University Health Science Center, School of Heath Professions’ 35th Anniversary Celebration, Lubbock, Texas, September 2018. “Medical Errors: The Third Leading Cause of Death in the US.”

  Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, October 2018. “Clinical Excellence, Preventing Diagnostic Errors, and Cost Reduction through Better Lab Utilization”.

  Lifespan, Providence, RI. October 2018. “Appropriate Utilization of Laboratory Tests through a Diagnostic Management Team: Clinical and Financial Benefits.”

  Clinical Laboratory Improvement Advisory Committee, Atlanta, GA. November 2018. “The National Report on Diagnostic Errors: Implications for Laboratory Practice.”

  Pathology Grand Rounds, Medical College of Wisconsin, Milwaukee, WI. November 2018. “Medical Errors: The Third Leading Cause of Death in the US.”

  Clinical Diagnostics & Research, Labroots (webinar). November 2018. “Diagnostic Management Teams: Implementation Obstacles.”

  Association for Pathology Informatics Webinar Series. November 2018. “Obstacles to Widespread Implementation of Diagnostic Management Team Services.”

  Sunquest Webinar Series. November 2018. “IT Support for Diagnostic Management Teams.”

  Healthology Symposium, Oakland University, Rochester, MI. April 2019. “Obstacles to Widespread Implementation of Diagnostic Management Team Services.”

  Healthology Symposium, Oakland University, Rochester, MI. May 2019. “Role of the Laboratory in Reducing Diagnostic Errors” (Crucial Conversations with Janelle Chiasera, Ph.D.).

  Becker’s Health IT and Clinical Leadership and Pharmacy 2019. Chicago, IL. “Clinical Leadership and Quality at the University of Texas Medical Branch.” (with Eric Walser, M.D.)

  Grand Rounds, Cook Children’s Medical Center, Fort Worth, TX, October 2019. “Medical Errors: The Third Leading Cause of Death in the US.”

  University of Miami Annual Pathology Conference, Miami, FL. January 2020. “The Diagnostic Management Team: Past, Present and Future.”

  University of Miami Annual Pathology Conference, Miami, FL. January 2020. “Appropriate Utilization of Laboratory Tests Through a Diagnostic Management Team: Clinical and Financial Benefits.”

  University of Miami Annual Pathology Conference, Miami, FL. January 2020. “The Worst Misdiagnosis of All: The Incorrect Diagnosis of Child Abuse.”

  Dr. Robert Zhong Research Seminar, Schulich School of Medicine and Dentistry, Western University, Ontario, London, Canada. February 2020. “Medical Errors: A Major Cause of Death Across the World.”

  Webinar for Abbott Laboratories. May 2020. “Creating Clinical Engagement in Discrete Pandemic Phases.”

  Webinar for SelectScience. June 2020. “The Roles of the Doctoral Laboratory Staff in the COVID-19 Pandemic: Are we doing enough?”

  Grand Rounds, Beth Israel Deaconess Medical Center. September 2020. “The Diagnostic Management Team: Past, Present, and Future.” (virtual)

• Invited Lectures – Other

  Massachusetts General Hospital, Boston, MA. March 1989. "The Availability of Cellular Arachidonate for Prostaglandin Production."

  University of Massachusetts School of Medicine, Worcester, MA. October 1991. "Laboratory Medicine Training at the Massachusetts General Hospital."

  Grand Rounds, MGH Department of Medicine, Boston, MA. July 1994. "von Willebrand's Disease." Cardiovascular Anesthesia Continuing Education Course, Harvard Medical School, Boston, MA. September 1994. "Diagnosis and Treatment of Common Coagulopathies."

  Grand Rounds, MGH Department of Medicine, Boston, MA. December 1996. "Hypercoagulable States."

  Neurology Grand Rounds, Massachusetts General Hospital, Boston, MA. May 1997. "Fatty Acid Ethyl Ester: A New Ethanol Metabolite Associated with Toxicity and Intoxication."

  Anesthesia Grand Rounds, Massachusetts General Hospital, Boston, MA. July 1997. "Alcohol Abuse: Mechanisms of Toxicity and Monitoring Intake."

  Rheumatology Grand Rounds, Massachusetts General Hospital, September 1999. “Antiphospholipid Antibodies.”

  Reproductive Endocrinology & Gynecology Seminar Series, Brigham and Women’s Hospital, Boston, MA. September 2003. “Hypercoagulable States.”

  Massachusetts General Hospital Department of Anesthesia Grand Rounds, Boston, MA. January 2005. “Hypercoagulable States.”

  Obstetrics and Gynecology Grand Rounds, Massachusetts General Hospital, Boston, MA. April 2007. “Hypercoagulable States and Their Many Connections to Obstetrics and Gynecology.”

  Rheumatology Grand Rounds, University of Massachusetts Medical School, Worcester, MA. September 2007. “Antiphospholipid Antibodies: What They Are and What to Do About Them.”

  Advances in Rheumatology, Harvard Continuing Medical Education Course, Boston, MA. September 2007. “Coagulopathies”.

  Clinical Pharmacology Grand Rounds, Vanderbilt University Medical Center, Nashville, TN. February 2010. “Fatty Acid Abnormalities in Cystic Fibrosis.”

  Cardiology 2013: Advances in Science and Practice. Vanderbilt University School of Medicine, Nashville, TN. February 2013. “Beyond the Clot: The Evaluation of Hypercoagulable States.”

  Health System Advisory Board, University of Texas Medical Branch-Galveston., Galveston, TX. January 2015. “Advances in Pathology: How UTMB Can Become Even More of a Leader in Pathology.”

  Dean’s Lecture. Graduate School of Biomedical Sciences, University of Texas Medical Branch at Galveston. Galveston, TX. March 2015. “Personalized Medicine and the Amazing Progress toward Life-saving Treatments for Patients with Cystic Fibrosis.”

  Orthopaedic Surgery Grand Rounds, University of Texas Medical Branch-Galveston, TX, April 2015. “Anticoagulants and Antiplatelet Agents: Indications and Monitoring.”

  UTMB Health Policy Dialogue Seminar Series. University of Texas Medical Branch-Galveston, TX. November 2015. “Improving Diagnosis in Health Care.”

  Department of Pathology Grand Rounds, University of Texas Medical Branch-Galveston, TX, September 2016. “UTMB Department of Pathology: The Year Finished. The Year Ahead.”

  Department of Internal Residents Conference, University of Texas Medical Branch-Galveston, TX, September 2016. “Anticoagulants: Indications and Laboratory Monitoring.”

  Osler Scholars, University of Texas Medical Branch-Galveston, TX, November 2016. “The Worst Misdiagnosis of All: The Incorrect Diagnosis of Child Abuse.”

  Department of Pathology Grand Rounds, University of Texas Medical Branch-Galveston, TX, November 2016. “The Worst Misdiagnosis of All: The Incorrect Diagnosis of Child Abuse.”

  Department of Pathology Grand Rounds, University of Texas Medical Branch-Galveston, TX, September 2017. “One Year Objective Review of Activities in the Department of Pathology.”

  Department of Pathology Grand Rounds, University of Texas Medical Branch-Galveston, TX, September 2018. “One Year Objective Review of Activities in the Department of Pathology.”

  Department of Orthopaedic Surgery and Rehabilitation Conference, University of Texas Medical Branch, League City, TX, October 2018. “Anticoagulant and Antiplatelet Use in Orthopedic Surgery.”

  Department of Pathology Grand Rounds, University of Texas Medical Branch-Galveston, TX, October 2019. “The State of the UTMB Department of Pathology.”

  COVID-19 Research Virtual Workshop, University of Texas Medical Branch-Galveston, TX, June 2020. “Are We Doing Enough with Testing for COVID-19 to Answer the Important Questions for Patients and Healthcare Practitioners?”

  Virtual Summer Series, University of Texas Medical Branch-Galveston, TX, July 2020. “Are We Doing Enough with Testing for COVID-19 to Answer the Important Questions for Patients and Healthcare Practitioners?”